中国心脏起搏与心电生理杂志

参考文献

1 January CT,Wann LS,Alpert JS,et al.2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society[J].Circulation,2014,130(23):e199

2 Haissaguerre M,Jais P,Shah DC,et al.Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins[J].N Engl J Med,1998,339(10):659

3 Liu J,Huang CX,Bao MW,Wang T.Ectopic activity induced by elevated atrial pressure in rabbit pulmonary vein in vitro[J].Chin Med J(Engl),2005,118(14):1210

4 王晞,黄从新,王腾.兔肺静脉肌袖心肌细胞动作电位和钾、钙离子流特性的研究[J].中华心血管病杂志,2002,30(4):232

5 王晞,黄从新,江洪,等.兔肺静脉心肌袖组织学特性研究[J].中华心律失常学杂志,2003,7(4):241

6 谢双伦,黄从新,江洪,等.兔上下腔静脉中的心肌细胞组织结构研究[J].中华心律失常学杂志,2003,7(4):234

7 杨延宗,黄从新,高连君,等.阵发性心房颤动大静脉电隔离后肌袖内自发电活动的特点[J].中华心律失常学杂志,2004,8(3):146

8江洪,黄从新,唐其柱,等.肺静脉异常电活动引起持续性心房颤动的电生理特点和消融治疗[J].中华心血管病杂志,2004,32(3):211

9 Moe GK,Abildskov JA.Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge[J].Am Heart J,1959,58(1):59

10 Mandapati R,Skanes A,Chen J,et al.Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart[J].Circulation,2000,101(2):194

11 Pandit SV,Jalife J.Rotors and the dynamics of cardiac fibrillation[J].Circ Res,2013,112(5):849

12 江洪.心房颤动发病机制研究十年回顾[J].中华心律失常学杂志,2008,12(增刊):10

13 Iwasaki YK,Nishida K,Kato T,et al.Atrial fibrillation pathophysiology implications for management[J].Circulation,2011,124(20):2 264

14 Goette A,Staack T,Rocken C,et al.Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation[J].J Am Coll Cardiol,2000,35(6):1 669

15 Iravanian S,Duley SC.The renin-angiotensin-aldosterone system(RAAS)and cardiac arrhythmias[J].Heart Rhythm,2008,5(6):S12

16 Khatib R,Joseph P,Briel M,et al.Blockade of the renin-angiotensin-aldosterone system(RAAS)for primary prevention of non-valvular atrial fibrillation:A systematic review and meta analysis of randomized controlled trials[J].Int J Cardiol,2013,165(1):17

17 Frustaci A,Chimenti C,Bellocci F,et al.Histological substrate of atrial biopsies in patients with lone atrial fibrillation[J].Circulation,1997,96(4):1 180

18 Engelmann MDM,Svendsen JH.Inflammation in the genesis and perpetuation of atrial fibrillation[J].Eur Heart J,2005,26(20):2 083

19 Wu G,Cheng M,Huang H,et al.A variant of IL6R is associated with the recurrence of atrial fibrillation after catheter ablation in a chinese han population[J].PloS One,2014,9(6)

20 Dudley SC,Hoch NE,McC ann LA,et al.Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage——Role of the NADPH and xanthine oxidases[J].Circulation,2005,112(9):1 266

21 Carnes CA,Chung MK,Nakayama T,et al.Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation[J].Circ Res,2001,89(6):E32

22 Shen MJ,Zipes DP.Role of the autonomic nervous system in modulating cardiac arrhythmias[J].Circ Res,2014,114(6):1 004

23 Sheng X,Scherlag BJ,Yu LL,et al.Prevention and reversal of atrial fibrillation inducibility and autonomic remodeling by low-level vagosympathetic nerve stimulation[J].J Am Coll Cardiol,2011,57(5):563

24 Stavrakis S,Humphrey MB,Scherlag BJ,et al.Low-level transcutaneous electrical vagus nerve stimulation suppresses atrial fibrillation[J].J Am Coll Cardiol,2015,65(9):867

25 Wang X,Huang C,Zhao Q,et al.Effect of renal sympathetic denervation on the progression of paroxysmal atrial fibrillation in canines with long-term intermittent atrial pacing[J].Europace,2015,17(4):647

26 Wang XL,Zhao QY,Huang H,et al.Effect of renal sympathetic denervation on atrial substrate remodeling in ambulatory canines with prolonged atrial pacing[J].PloS One,2013,8(5):e64 611

27 Wang XZ,Zhao QY,Deng HP,et al.Effects of renal sympathetic denervation on the atrial electrophysiology in dogs with pacing-induced heart failure[J].Pacing Clin Electrophysiol,2014,37(10):1 357

28 Zhao QY,Yu SB,Zou MH,et al.Effect of renal sympathetic denervation on the inducibility of atrial fibrillation during rapid atrial pacing[J].J Interv Card Electrophysiol,2012,35(2):119

29 Zhou J,Scherlag BJ,Edwards J,et al.Gradients of atrial refractoriness and inducibility of atrial fibrillation due to stimulation of ganglionated plexi[J].J Cardiovasc Electrophysiol,2007,18(1):83

30 Katritsis DG,Pokushalov E,Romanov A,et al.Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation:a randomized clinical trial[J].J Am Coll Cardiol,2013,62(24):2 318

31 Huxley RR,Lopez FL,Folsom AR,et al.Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors:The Atherosclerosis Risk in Communities(ARIC)Study[J].Circulation,2011,123(14):1 501

32 Fein AS,Shvilkin A,Shah D,et al.Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation[J].J Am Coll Cardiol,2013,62(4):300

33 Waldo AL,Feld GK.Inter-relationships of atrial fibrillation and atrial flutter[J].J Am Coll Cardiol,2008,51(8):779

34 Packer DL,Bardy GH,Worley SJ,et al.Tachycardia-induced cardiomyopathy:a reversible form of left ventricular dysfunction[J].Am J Cardiol,1986,57(8):563

35 Shinbane JS,Wood MA,Jensen DN,et al.Tachycardia-induced cardiomyopathy:a review of animal models and clinical studies[J].J Am Coll Cardiol,1997,29(4):709

36 Fatkin D,Kelly RP,Feneley MP.Relations between left atrial appendage blood flow velocity,spontaneous echocardiographic contrast and thromboembolic risk in vivo[J].J Am Coll Cardiol,1994,23(4):961

37 Flegel KM,Shipley MJ,Rose G.Risk of stroke in non-rheumatic atrial fibrillation[J].Lancet(London,England),1987,1(8532):526

38 Wolf PA,Abbott RD,Kannel WB.Atrial fibrillation as an independent risk factor for stroke:the Framingham Study[J].Stroke,1991,22(8):983

39 Laupacis A,Boysen G,Connolly S,et al.Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation.Analysis of pooled data from five randomized controlled trials[J].Arch Intern Med,1994,154(13):1 449

40 Thihalolipavan S,Morin DP.Atrial fibrillation and congestive heart failure[J].Heart Fail Clin,2014,10(2):305

41 Wang TJ,Larson MG,Levy D,et al.Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality——The Framingham Heart Study[J].Circulation,2003,107(23):2 920

42 Maisel WH,Stevenson LW.Atrial fibrilation in heart failure:epidemiology,pathophysiology,and rationale for therapy[J].Am J Cardiol,2003,91(6A):2D

43 Anter E,Jessup M,Callans DJ.Atrial fibrillation and heart failure treatment considerations for a dual epidemic[J].Circulation,2009,119(18):2 516

44 Nicklao JM,Pitt B,Timmis S,et al.Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.The SOLVD Investigattors[J].N Engl J Med,1992,327(10):685

45 Hagens VE,Ranchor AV,Van Sonderen E,et al.Effect of rate or rhythm control on quality of life in persistent atrial fibrillation——Results from the Rate Control Versus Electrical Cardioversion(RACE)study[J].J Am Coll Cardiol,2004,43(2):241

46 Jenkins LS,The AI.Quality of life in atrial fibrillation:The Atrial Fibrillation Follow-up Investigation of Rhythm Management(AFFIRM)study[J].Am Heart J,2005,149(1):112

47 Reynolds MR,Lavelle T,Essebag V,et al.Influence of age,sex,and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation:The Fibrillation Registry Assessing Costs,Therapies,Adverse events and Lifestyle(FRACTAL)study[J].Am Heart J,2006,152(6):1 097

48 Spertus J,Dorian P,Bubien R,et al.Development and validation of the atrial fibrillation effect on quality-of-life(AFEQT)questionnaire in patients with atrial fibrillation[J].Circ-Arrhythmia Electrophysiol,2011,4(1):15

49 Bunch TJ,Weiss JP,Crandall BG,et al.Atrial fibrillation is independently associated with senile,vascular,and Alzheimer's dementia[J].Heart Rhythm,2010,7(4):433

50 Marzona I,O'Donnell M,Teo K,et al.Increased risk of cognitive and functional decline in patients with atrial fibrillation:results of the ONTARGET and TRANSCEND studies[J].Can Med Assoc J,2012,184(6):e329

51 Benjamin EJ,Wolf PA,D'Agostino RB,et al.Impact of atrial fibrillation on the risk of death:the Framingham Heart Study[J].Circulation,1998,98(10):946

52 Klein AL,Grimm RA,Murray RD,et al.Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation[J].N Engl J Med,2001,344(19):1 411

53 Manning WJ,Silverman DI,Keighley CS,et al.Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation:final results of a prospective4 .5-year study[J].J Am Coll Cardiol,1995,25(6):1 354

54 梁桂琤.心腔内超声在左心快速性心律失常的消融概述[J].心血管病学进展,2011,32(3):386

55 Marrouche NF,Wilber D,Hindricks G,et al.Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation:The DECAAF Study[J].JAMA-J Am Med Assoc,2014,311(5):498

56 Burstein B,Nattel S.Atrial fibrosis:Mechanisms and clinical relevance in atrial fibrillation[J].J Am Coll Cardiol,2008,51(8):802

57 Wattigney WA,Mensah GA,Croft JB.Increasing trends in hospitalization for atrial fibrillation in the United States,1985 through1999:implications for primary prevention[J].Circulation,2003,108(6):711

58 Lin HJ,Wolf PA,Kelly-Hayes M,et al.Stroke severity in atrial fibrillation.The Framingham Study[J].Stroke,1996,27(10):1760

59 Hart RG,Pearce LA,Aguilar MI.Meta-analysis:antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation[J].Ann Intern Med,2007,146(12):857

60 January C,Wann L,Alpert J,et al.AHA/ACC/HRS guideline for the management of patients with atrial fibrillation:A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.Developed in Collaboration With the Society of Thoracic Surgeons[J].J Am Coll Cardiol,2014,1097(14):01 740

61 Giugliano RP,Ruff CT,Braunwald E,et al.Edoxaban versus warfarin in patients with atrial fibrillation[J].N Engl J Med,2013,369(22):2 093

62 Patel MR,Mahaffey KW,Garg J,et al.Rivaroxaban versus warfarin in nonvalvular atrial fibrillation[J].N Engl J Med,2011,365(10):883

63 Granger CB,Alexander JH,McM urray JJ,et al.Apixaban versus warfarin in patients with atrial fibrillation[J].N Engl J Med,2011,365(11):981

64 Connolly SJ,Ezekowitz MD,Yusuf S,et al.Dabigatran versus warfarin in patients with atrial fibrillation[J].N Engl J Med,2009,361(12):1 139

65 Moulton AW,Singer DE,Haas JS.Risk factors for stroke in patients with nonrheumatic atrial fibrillation:a case-control study[J].Am J Med,1991,91(2):156

66 Gage BF,Waterman AD,Shannon W,et al.Validation of clinical classification schemes for predicting stroke:results from the National Registry of Atrial Fibrillation[J].JAMA,2001,285(22):2 864

67 Friberg L,Rosenqvist M,Lindgren A,et al.High prevalence of atrial fibrillation among patients with ischemic stroke[J].Stroke,2014,45(9):2 599

68 Maron BJ,Olivotto I,Bellone P,et al.Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy[J].J Am Coll Cardiol,2002,39(2):301

69 Olivotto I,Cecchi F,Casey SA,et al.Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy[J].Circulation,2001,104(21):2 517

70 Zabalgoitia M,Halperin JL,Pearce LA,et al.Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation.Stroke Prevention in Atrial Fibrillation III Investigators[J].J Am Coll Cardiol,1998,31(7):1 622

71 Lip GY,Nieuwlaat R,Pisters R,et al.Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach:the euro heart survey on atrial fibrillation[J].Chest,2010,137(2):263

72 Guo YT,Apostolakis S,Blann AD,et al.Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation[J].Int J Cardiol,2013,168(2):904

73 Lip GY,Frison L,Halperin JL,et al.Identifying patients at high risk for stroke despite anticoagulation:a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort[J].Stroke,2010,41(12):2 731

74 Pisters R,Lane DA,Nieuwlaat R,et al.A novel user-friendly score(HAS-BLED)to assess 1-year risk of major bleeding in patients with atrial fibrillation:the Euro Heart Survey[J].Chest,2010,138(5):1093

75 Lip GY,Frison L,Halperin JL,et al.Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation:the HAS-BLED(Hypertension,Abnormal Renal/Liver Function,Stroke,Bleeding History or Predisposition,Labile INR,Elderly,Drugs/Alcohol Concomitantly)score[J].J Am Coll Cardiol,2011,57(2):173

76 Olesen JB,Lip GY,Lindhardsen J,et al.Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation:A net clinical benefit analysis using a"real world"nationwide cohort study[J].Thromb Haemost,2011,106(4):739

77 Van Spall HGC,Wallentin L,Yusuf S,et al.Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries an analysis of patients receiving warfarin in the randomized evaluation of longterm anticoagulation therapy(RE-LY)trial[J].Circulation,2012,126(19):2 309

78 Blackshear JL,Baker VS,Rubino F,et al.Adjusted-dose warfarin versus low-intensity,fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation:Stroke Prevention in Atrial Fibrillation III randomised clinical trial[J].Lancet,1996,348(9028):633

79 Miller VT,Rothrock JF,Pearce LA,et al.Ischemic stroke in patients with atrial fibrillation:effect of aspirin according to stroke mechanism.Stroke Prevention in Atrial Fibrillation Investigators[J].Neurology,1993,43(1):32

80 Mcbride R,Chesebro JH,Wiebers DO,et al.Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation:Stroke Prevention in Atrial Fibrillation II Study[J].Lancet,1994,343(8899):687

81 Connolly S,Pogue J,Hart R,et al.Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events(ACTIVE W):a randomised controlled trial[J].Lancet,2006,367(9526):1 903

82 Hart RG,Pearce LA,Rothbart RM,et al.Stroke with intermittent atrial fibrillation:incidence and predictors during aspirin therapy.Stroke Prevention in Atrial Fibrillation Investigators[J].J Am Coll Cardiol,2000,35(1):183

83 Collins LJ,Silverman DI,Douglas PS,et al.Cardioversion of nonrheumatic atrial fibrillation.Reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrialthrombus resolution[J].Circulation,1995,92(2):160

84 Prystowsky EN.Management of atrial fibrillation:therapeutic options and clinical decisions[J].Am J Cardiol,2000,85(10A):3 D

85 Gallagher MM,Hennessy BJ,Edvardsson N,et al.Embolic complications of direct current cardioversion of atrial arrhythmias:association with low intensity of anticoagulation at the time of cardioversion[J].J Am Coll Cardiol,2002,40(5):926

86 Legrand M,Mateo J,Aribaud A,et al.The use of dabigatran in elderly patients[J].Arch Intern Med,2011,171(14):1 285

87 eidl K,Rameken M,Drogemuller A,et al.Embolic events in patients with atrial fibrillation and effective anticoagulation:value of transesophageal echocardiography to guide direct-current cardioversion.Final results of the Ludwigshafen Observational Cardioversion Study[J].J Am Coll Cardiol,2002,39(9):1 436

88 Weigner MJ,Thomas LR,Patel U,et al.Early cardioversion of atrial fibrillation facilitated by transesophageal echocardiography:short-term safety and impact on maintenance of sinus rhythm at 1year[J].Am J Med,2001,110(9):694

89 Khan IA.Transient atrial mechanical dysfunction(stunning)after cardioversion of atrial fibrillation and flutter[J].Am Heart J,2002,144(1):11

90 Gallagher AM,Setakis E,Plumb JM,et al.Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients[J].Thromb Haemost,2011,106(5):968

91 Connolly SJ,Eikelboom J,Joyner C,et al.Apixaban in patients with atrial fibrillation[J].N Engl J Med,2011,364(9):806

92 Fox KA,Piccini JP,Wojdyla D,et al.Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment[J].Eur Heart J,2011,32(19):2 387

93 Mant J,Hobbs FD,Fletcher K,et al.Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation(the Birmingham Atrial Fibrillation Treatment of the Aged Study,BAFTA):a randomised controlled trial[J].Lancet,2007,370(9586):493

94 Camm AJ,Kirchhof P,Lip GY,et al.Guidelines for the management of atrial fibrillation:the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology(ESC)[J].Europace,2010,12(10):1 360

95 Shen AY,Yao JF,Brar SS,et al.Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation[J].J Am Coll Cardiol,2007,50(4):309

96 Ogawa S,Aizawa Y,Atarashi H,et al.Guidelines for pharmacotherapy of atrial fibrillation(JCS 2008):digest version[J].Circ J,2010,74(11):2 479

97 Lip GY,Windecker S,Huber K,et al.Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions:a joint consensus document of the European Society of Cardiology Working Group on Thrombosis,European Heart Rhythm Association(EHRA),European Association of Percutaneous Cardiovascular Interventions(EAPCI)and European Association of AcuteCardiac Care(ACCA)endorsed by the Heart Rhythm Society(HRS)and Asia-Pacific Heart Rhythm Society(APHRS)[J].Eur Heart J,2014,35(45):3 155

98 Lip GY,Huber K,Andreotti F,et al.Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting:executive summary——a Consensus Document of the European Society of Cardiology Working Group on Thrombosis,endorsed by the European Heart Rhythm Association(EHRA)and the European Association of Percutaneous Cardiovascular Interventions(EAPCI)[J].Eur Heart J,2010,31(11):1 311

99 Lamberts M,Gislason GH,Lip GYH,et al.Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant:a nationwide cohort study[J].Circulation,2014,129(15):1 577

100 Dewilde WJ,Oirbans T,Verheugt FW,et al.Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention:an open-label,randomised,controlled trial[J].Lancet,2013,381(9872):1107

101 Lamberts M,Gislason GH,Olesen JB,et al.Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention[J].J Am Coll Cardiol,2013,62(11):981

102 Maeda K,Koga M,Okada Y,et al.Nationwide survey of neurospecialists'opinions on anticoagulant therapy after intracerebral hemorrhage in patients with atrial fibrillation[J].J Neurol Sci,2012,312(1-2):82

103 Limdi NA,Veenstra DL.Warfarin pharmacogenetics[J].Pharmacotherapy,2008,28(9):1 084

104 Lip GYH,Wang KL,Chiang CE.Non-vitamin K antagonist oral anticoagulants(NOACs)for stroke prevention in Asian patients with atrial fibrillation:Time for a reappraisal[J].Int J Cardiol,2015,180:246

105 Lin HJ,Wolf PA,Benjamin EJ,et al.Newly diagnosed atrial fibrillation and acute stroke.The Framingham Study[J].Stroke,1995,26(9):1 527

106 Seet RC,Friedman PA,Rabinstein AA.Prolonged rhythm monitoring for the detection of occult paroxysmal atrial fibrillation in ischemic stroke of unknown cause[J].Circulation,2011,124(4):477

107 Kishore A,Vail A,Majid A,et al.Detection of atrial fibrillation after ischemic stroke or transient ischemic attack:a systematic review and meta-analysis[J].Stroke,2014,45(2):520

108 Cotter PE,Martin PJ,Ring L,et al.Incidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke[J].Neurology,2013,80(17):1546-1550

109 Sanna T,Diener HC,Passman RS,et al.Cryptogenic stroke and underlying atrial fibrillation[J].N Engl J Med,2014,370(26):2 478

110 Quinn FR,Gladstone D.Screening for undiagnosed atrial fibrillation in the community[J].Curr Opin Cardiol,2014,29(1):28

111 Birnie DH,Healey JS,Wells GA,et al.Pacemaker or defibrillator surgery without interruption of anticoagulation[J].N Engl J Med,2013,368(22):2 084

112 Heidbuchel H,Verhamme P,Alings M,et al.European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation[J].Europace,2013,15(5):625

113 Ahmed I,Gertner E,Nelson WB,et al.Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation[J].Heart Rhythm,2010,7(6):745

114 Di Biase L,Burkhardt JD,Mohanty P,et al.Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation[J].Circulation,2010,121(23):2 550

115 Di Biase L,Burkhardt JD,Santangeli P,et al.Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation(AF)Patients Undergoing Catheter Ablation(COMPARE)Randomized Trial[J].Circulation,2014,129(25):2 638

116 Lakkireddy D,Reddy YM,Di Biase L,et al.Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation results from a multicenter prospective registry[J].J Am Coll Cardiol,2012,59(13):1 168

117 Nin T,Sairaku A,Yoshida Y,et al.A randomized controlled trial of dabigatran versus warfarin for periablation anticoagulation in patients undergoing ablation of atrial fibrillation[J].Pacing Clin Electrophysiol,2013,36(2):172

118 Cappato R,Marchlinski FE,Hohnloser SH,et al.Uninterrupted rivaroxaban vs.uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation[J].Eur Heart J,2015,36(28):1 805

119 Al-Saady N,Obel O,Camm A.Left atrial appendage:structure,function,and role in thromboembolism[J].Heart,1999,82(5):547

120 Holmes DR,Reddy VY,Turi ZG,et al.Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation:a randomised non-inferiority trial[J].The Lancet,2009,374(9689):534

121 Reddy VY,Holmes D,Doshi SK,et al.Safety of percutaneous left atrial appendage closure results from the watchman left atrial appendage system for embolic protection in patients with AF(PROTECT AF)clinical trial and the continued access registry[J].Circulation,2011,123(4):417

122 Reddy VY,Sievert H,Halperin J,et al.Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation:a randomized clinical trial[J].JAMA-J Am Med Assoc,2014,312(19):1988

123 Lam YY,Yip GW,Yu CM,et al.Left atrial appendage closure with Amplatzer cardiac plug for stroke prevention in atrial fibrillation:Initial Asia-Pacific experience[J].Catheter Cardiovasc In-terv,2012,79(5):794

124 Park JW,Bethencourt A,Sievert H,et al.Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation:initial European experience[J].Catheter Cardiovasc Interv,2011,77(5):700

125 Tzikas A,Shakir S,Sievert H,et al.Left atrial appendage occlusion for stroke prevention in atrial fibrillation:multicenter experience with the Amplatzer Cardiac Plug[J].Eur Heart J,2014,35:727

126 Bartus K,Han FT,Bednarek J,et al.Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation:initial clinical experience[J].J Am Coll Cardiol,2013,62(2):108

127 Chatterjee S,Herrmann HC,Wilensky RL,et al.Safety and procedural success of left atrial appendage exclusion with the Lariat Device:a systematic review of published reports and analytic review of the FDA MAUDE database[J].JAMA internal medicine,2015,175(7):1 104

128 Price MJ,Gibson DN,Yakubov SJ,et al.Early safety and efficacy of percutaneous left atrial appendage suture ligation results from the US Transcatheter LAA Ligation Consortium[J].J Am Coll Cardiol,2014,64(6):565

129 中华医学会心电生理和起搏分会,中华医学会心血管病学分会,中国医师协会心律学专业委员会.左心耳干预预防心房颤动患者血栓栓塞事件:目前的认识和建议[J].中国心脏起搏与心电生理杂志,2014,28(6):471

130 Camm AJ,Lip GY,De Caterina R,et al.2012 focused update of the ESC Guidelines for the management of atrial fibrillation An update of the 2010 ESC Guidelines for the management of atrial fibrillation developed with the special contribution of the European Heart Rhythm Association[J].Eur Heart J,2012,33(21):2 719

131 Kanderian AS,Gillinov AM,Pettersson GB,et al.Success of surgical left atrial appendage closure assessment by transesophageal echocardiography[J].J Am Coll Cardiol,2008,52(11):924

132 Katz ES,Tsiamtsiouris T,Applebaum RM,et al.Surgical left atrial appendage ligation is frequently incomplete:a transesophageal echocardiographic study[J].J Am Coll Cardiol,2000,36(2):468

133 Garcia-Fernandez MA,Perez-David E,Quiles J,et al.Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis——A transesophageal echocardiographic study[J].J Am Coll Cardiol,2003,42(7):1 253

134 Healey JS,Crystal E,Lamy A,et al.Left Atrial Appendage Occlusion Study(LAAOS):results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke[J].Am Heart J,2005,150(2):288

135 Hernandez-Estefania R,Praschker BL,Bastarrika G,et al.Left atrial appendage occlusion by invagination and double suture technique[J].Eur J Cardiothorac Surg,2012,41(1):134

136 Ailawadi G,Gerdisch MW,Harvey RL,et al.Exclusion of the left atrial appendage with a novel device:early results of a multicenter trial[J].J Thorac Cardiovasc Surg,2011,142(5):1 002

137 Emmert MY,Puippe G,Baumuller S,et al.Safe,effective and durable epicardial left atrial appendage clip occlusion in patients with atrial fibrillation undergoing cardiac surgery:first long-term results from a prospective device trial[J].Eur J Cardiothorac Surg,2014,45(1):126

138 Blackshear JL,Johnson WD,Odell JA,et al.Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation[J].J Am Coll Cardiol,2003,42(7):1 249

139 Wolf RK,Schneeberger EW,Osterday R,et al.Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation[J].J Thorac Cardiovasc Surg,2005,130(3):797

140 Ohtsuka T,Ninomiya M,Nonaka T,et al.Thoracoscopic stand-alone left atrial appendectomy for thromboembolism prevention in nonvalvular atrial fibrillation[J].J Am Coll Cardiol,2013,62(2):103

141 Kim R,Baumgartner N,Clements J.Routine left atrial appendage ligation during cardiac surgery may prevent postoperative atrial fibrillation-related cerebrovascular accident[J].J Thorac Cardiovasc Surg,2013,145(2):582

142 Bando K,Kobayashi J,Hirata M,et al.Early and late stroke after mitral valve replacement with a mechanical prosthesis:risk factor analysis of a 24-year experience[J].J Thorac Cardiovasc Surg,2003,126(2):358

143 Lee CH,Kim JB,Jung SH,et al.Left atrial appendage resection versus preservation during the surgical ablation of atrial fibrillation[J].Ann Thorac Surg,2014,97(1):124

144 Yamanaka K,Sekine Y,Nonaka M,et al.Left atrial appendage contributes to left atrial booster function after the maze procedure:quantitative assessment with multidetector computed tomography[J].Eur J Cardiothorac Surg,2010,38(3):361

145 Yoshihara F,Nishikimi T,Kosakai Y,et al.Atrial natriuretic peptide secretion and body fluid balance after bilateral atrial appendectomy by the maze procedure[J].J Thorac Cardiovasc Surg,1998,116(2):213

146 Albage A,Kenneback G,van der Linden J,et al.Improved neurohormonal markers of ventricular function after restoring sinus rhythm by the maze procedure[J].Ann Thorac Surg,2003,75(3):790

147 Zimetbaum PJ.Dronedarone for atrial fibrillation——an odyssey[J].N Engl J Med,2009,360(18):1 811

148 Weerasooriya R,Davis M,Powell A,et al.The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial(AIRCRAFT)[J].J Am Coll Cardiol,2003,41(10):1 697

149 Sherman DG,Kim SG,Boop BS,et al.Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of sinus Rhythm Management(AFFIRM)Study[J].Arch Intern Med,2005,165(10):1 185

150 Van Gelder IC,Groenveld HF,Crijns H,et al.Lenient versus strict rate control in patients with atrial fibrillation[J].N Engl J Med,2010,362(15):1 363

151 Jordaens L,Trouerbach J,Calle P,et al.Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo[J].Eur Heart J,1997,18(4):643

152 Farshi R,Kistner D,Sarma JSM,et al.Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise:a crossover open-label study of five drug regimens[J].J Am Coll Cardiol,1999,33(2):304

153 Kochiadakis GE,Kanoupakis EM,Kalebubas MD,et al.Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization:a single-blinded crossover study[J].Europace,2001,3(1):73

154 Koh KK,Kwon KS,Park HB,et al.Efficacy and safety of digoxin alone and in combination with low-dose diltiazem or betaxolol to control ventricular rate in chronic atrial fibrillation[J].Am J Cardiol,1995,75(1):88

155 Corley SD,Epstein AE,DiM arco JP,et al.Relationships between sinus rhythm,treatment,and survival in the atrial fibrillation follow-up investigation of rhythm management(AFFIRM)study[J].Circulation,2004,109(12):1 509

156 Rathore SS,Curtis JP,Wang YF,et al.Association of serum digoxin concentration and outcomes in patients with heart failure[J].JAMA-J Am Med Assoc,2003,289(7):871

157 Whitbeck MG,Charnigo RJ,Khairy P,et al.Increased mortality among patients taking digoxin-analysis from the AFFIRM study[J].Eur Heart J,2013,34(20):1 481

158 Perry G,Brown E,Thornton R,et al.Digitalis Investigation Group.The effect of digoxin on mortality and morbidity in patients with heart failure[J].N Engl J Med,1997,336(8):525

159 Gheorghiade M,Fonarow GC,van Veldhuisen DJ,et al.Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin:findings from post hoc propensity-matched analysis of the AFFIRM trial[J].Eur Heart J,2013,34(20):1489

160 Turakhia MP,Santangeli P,Winkelmayer WC,et al.Increased mortality associated with digoxin in contemporary patients with atrial fibrillation findings from the TREAT-AF Study[J].J Am Coll Cardiol,2014,64(7):660

161 Freeman JV,Reynolds K,Fang M,et al.Digoxin and risk of death in adults with atrial fibrillation:The ATRIA-CVRN Study[J].Circ-Arrhythmia Electrophysiol,2015,8(1):49

162 Vamos M,Erath JW,Hohnloser SH.Digoxin-associated mortality:a systematic review and meta-analysis of the literature[J].Eur Heart J,2015,36(28):1 831

163 Abrams J,Allen J,Allin D,et al.Efficacy and safety of esmolol vs propranolol in the treatment of supraventricular tachyarrhythmias:a multicenter double-blind clinical trial[J].Am Heart J,1985,110(5):913

164 Demircan C,Cikriklar HI,Engindeniz Z,et al.Comparison of the effectiveness of intravenous diltiazem and metoprolol in the management of rapid ventricular rate in atrial fibrillation[J].Emerg Med J,2005,22(6):411

165 Platia EV,Michelson EL,Porterfield JK,et al.Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter[J].Am J Cardiol,1989,63(13):925

166 Olshansky B,Rosenfeld LE,Warner AL,et al.The atrial fibrillation follow-up investigation of rhythm management(AFFIRM)study:Approaches to control rate in atrial fibrillation[J].J Am Coll Cardiol,2004,43(7):1 201

167 Khand AU,Rankin AC,Martin W,et al.Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure[J]?J Am Coll Cardiol,2003,42(11):1 944

168 Ellenbogen KA,Dias VC,Plumb VJ,et al.A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter:a multicenter study[J].J Am Coll Cardiol,1991,18(4):891

169 Phillips BG,Gandhi AJ,Sanoski CA,et al.Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter[J].Pharmacotherapy,1997,17(6):1238

170 Schamroth L.Immediate effects of intravenous verapamil on atrial fibrillation[J].Cardiovasc Res,1971,5(4):419

171 Gulamhusein S,Ko P,Carruthers SG,et al.Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil[J].Circulation,1982,65(2):348

172 Jacob AS,Nielsen DH,Gianelly RE.Fatal ventricular fibrillation following verapamil in Wolff-Parkinson-White syndrome with atrial fibrillation[J].Ann Emerg Med,1985,14(2):159

173 Siu CW,Lau CP,Lee WL,et al.Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation[J].Crit Care Med,2009,37(7):2 174

174 Hofmann R,Steinwender C,Kammler J,et al.Effects of a high dose intravenous bolus amiodarone in patients with atrial fibrillation and a rapid ventricular rate[J].Int J Cardiol,2006,110(1):27

175 Tse HF,Lam YM,Lau CP,et al.Comparison of digoxin versus low-dose amiodarone for ventricular rate control in patients with chronic atrial fibrillation[J].Clin Exp Pharmacol Physiol,2001,28(5-6):446

176 Wellens HJ,Brugada P,Abdollah H,et al.A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient[J].Circulation,1984,69(1):120

177 Badshah A,Mirza B,Janjua M,et al.Amiodarone-induced torsade de pointes in a patient with Wolff-Parkinson-White syndrome[J].Hellenic J Cardiol,2009,50(3):224

178 Nebojsa M,Dragan S,Nebojsa A,et al.Lethal outcome after intravenous administration of amiodarone in patient with atrial fibrillation and ventricular preexcitation[J].J Cardiovasc Electrophysiol,2011,22(9):1 077

179 Davy J-M,Herold M,Hoglund C,et al.Dronedarone for the control of ventricular rate in permanent atrial fibrillation:the Efficacy and safety of dRoned arone for the control of ventricular rate during atrial fibrillation(ERATO)study[J].Am Heart J,2008,156(3):527

180 Connolly SJ,Camm AJ,Halperin JL,et al.Dronedarone in highrisk permanent atrial fibrillation[J].N Engl J Med,2011,365(24):2 268

181 Kober L,Torp-Pedersen C,McM urray JJV,et al.Increased mortality after dronedarone therapy for severe heart failure[J].N Engl J Med,2008,358(25):2 678

182 Khan MN,Jais P,Cummings J,et al.Pulmonary-vein isolation for atrial fibrillation in patients with heart failure[J].N Engl J Med,2008,359(17):1 778

183 Wood MA,Brown-Mahoney C,Kay GN,et al.Clinical outcomes after ablation and pacing therapy for atrial fibrillation——A metaanalysis[J].Circulation,2000,101(10):1 138

184 Kay GN,Ellenbogen KA,Giudici M,et al.The ablate and pace trial:a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation.APT Investigators[J].J Interv Card Electrophysiol,1998,2(2):121

185 Brignole M,Menozzi C,Gianfranchi L,et al.Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation:a randomized,controlled study[J].Circulation,1998,98(10):953

186 Brignole M,Gianfranchi L,Menozzi C,et al.Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation:a randomized controlled study[J].Circulation,1997,96(8):2 617

187 Evans GT,Jr,Scheinman MM,Bardy G,et al.Predictors of inhospital mortality after DC catheter ablation of atrioventricular junction.Results of a prospective,international,multicenter study[J].Circulation,1991,84(5):1 924

188 Wang RX,Lee HC,Hodge DO,et al.Effect of pacing method on risk of sudden death after atrioventricular node ablation and pacemaker implantation in patients with atrial fibrillation[J].Heart Rhythm,2013,10(5):696

189 Geelen P,Brugada J,Andries E,et al.Ventricular fibrillation and sudden death after radiofrequency catheter ablation of the atrioventricular junction[J].Pacing Clin Electrophysiol,1997,20(2 Pt1):343

190 Tracy CM,Epstein AE,Darbar D,et al.2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities.a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J].Circulation,2012,126(14):1 784

191 Curtis AB,Worley SJ,Adamson PB,et al.Biventricular pacing for atrioventricular block and systolic dysfunction[J].N Engl J Med,2013,368(17):1 585

192 Leon AR,Greenberg JM,Kanuru N,et al.Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation:Effect of upgrading to biventricular pacing after chronic right ventricular pacing[J].J Am Coll Cardiol,2002,39(8):1258

193 Delle Karth G,Geppert A,Neunteufl T,et al.Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias[J].Crit Care Med,2001,29(6):1 149

194 Steinberg JS,Katz RJ,Bren GB,et al.Efficacy of oral diltiazem to control ventricular response in chronic atrial fibrillation at rest and during exercise[J].J Am Coll Cardiol,1987,9(2):405

195 Clemo HF,Wood MA,Gilligan DM,et al.Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias[J].Am J Cardiol,1998,81(5):594

196 Hou ZY,Chang MS,Chen CY,et al.Acute treatment of recentonset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone.A randomized,digoxin-controlled study[J].Eur Heart J,1995,16(4):521

197 Carlsson J,Miketic S,Windeler J,et al.Randomized trial of ratecontrol versus rhythm-control in persistent atrial fibrillation:the Strategies of Treatment of Atrial Fibrillation(STAF)study[J].J Am Coll Cardiol,2003,41(10):1 690

198 Gronefeld GC,Lilienthal J,Kuck KH,et al.Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation.Results from a prospective randomized study[J].Eur Heart J,2003,24(15):1 430

199 Hohnloser SH,Kuck KH,Lilienthal J.Rhythm or rate control in atrial fibrillation——Pharmacological Intervention in Atrial Fibrillation(PIAF):a randomised trial[J].Lancet,2000,356(9244):1 789

200 Ogawa S,Yamashita T,Yamazaki T,et al.Optimal treatment strategy for patients with paroxysmal atrial fibrillation:J-RHYTHM Study[J].Circ J,2009,73(2):242

201 Hagens VE,Vermeulen KM,Ten Vergert EM,et al.Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation--results from the RAte Control versus Electrical cardioversion(RACE)study[J].Eur Heart J,2004,25(17):1 542

202 Opolski G,Torbicki A,Kosior DA,et al.Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation:the results of the Polish How to Treat Chronic Atrial Fibrillation(HOT CAFE)Study[J].Chest,2004,126(2):476

203 Shelton RJ,Clark AL,Goode K,et al.A randomised,controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure:(CAFE-II Study)[J].Heart,2009,95(11):924

204 Yamashita T,Ogawa S,Aizawa Y,et al.Investigation of the optimal treatment strategy for atrial fibrillation in Japan[J].Circ J,2003,67(9):738

205 Freudenberger RS,Wilson AC,Kostis JB.Comparison of rate versus rhythm control for atrial fibrillation in patients with left ventricular dysfunction(from the AFFIRM Study)[J].Am J Cardiol,2007,100(2):247

206 Hagens VE,Crijns HJ,Van Veldhuisen DJ,et al.Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure:results from the Rate Control versus Electrical Cardioversion(RACE)study[J].Am Heart J,2005,149(6):1 106

207 Saksena S,Slee A,Waldo AL,et al.Cardiovascular outcomes in the AFFIRM Trial(Atrial Fibrillation Follow-Up Investigation of Rhythm Management).An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity scorematched analyses[J].J Am Coll Cardiol,2011,58(19):1 975

208 Van Gelder IC,Hagens VE,Bosker HA,et al.A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation[J].N Engl J Med,2002,347(23):1 834

209 Marshall DA,Levy AR,Vidaillet H,et al.Cost-effectiveness of rhythm versus rate control in atrial fibrillation[J].Ann Intern Med,2004,141(9):653

210 Perez A,Touchette DR,DiD omenico RJ,et al.Comparison of rate control versus rhythm control for management of atrial fibrillation in patients with coexisting heart failure:a cost-effectiveness analysis[J].Pharmacotherapy,2011,31(6):552

211 Talajic M,Khairy P,Levesque S,et al.Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation[J].J Am Coll Cardiol,2010,55(17):1 796

212 Wyse DG,Waldo AL,DiM arco JP,et al.A comparison of rate control and rhythm control in patients with atrial fibrillation[J].N Engl J Med,2002,347(23):1 825

213 Amerena J,Chen SA,Sriratanasathavorn C,et al.Insights into management of atrial fibrillation in Asia Pacific gained from baseline data from registry on cardiac rhythm disorders(Record AF-Asia Pacific[AP])registry[J].Am J Cardiol,2012,109(3):378

214 Oliveira LH,Mallmann FB,Botelho FN,et al.Cross-sectional study of treatment strategies on atrial fibrillation[J].Arq Bras Cardiol,2012,98(3):195

215 Singla S,Karam P,Deshmukh AJ,et al.Review of contemporary antiarrhythmic drug therapy for maintenance of sinus rhythm in atrial fibrillation[J].J Cardiovasc Pharmacol Ther,2012,17(1):12

216 Akoum NW,Wasmund SL,Lux RL,et al.Reverse electrical remodeling of the ventricles following successful restoration of sinus rhythm in patients with persistent atrial fibrillation[J].Pacing Clin Electrophysiol,2010,33(10):1 198

217 Friberg L,Hammar N,Edvardsson N,et al.The prognosis of patients with atrial fibrillation is improved when sinus rhythm is restored:report from the Stockholm Cohort of Atrial Fibrillation(SCAF)[J].Heart,2009,95(12):1 000

218 Okcun B,Yigit Z,Yildiz A,et al.What should be the primary treatment in atrial fibrillation:ventricular rate control or sinus rhythm control with long-term anticoagulation[J]?J Int Med Res,2009,37(2):464

219 Steg PG,Alam S,Chiang CE,et al.Symptoms,functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation:data from the realise AF cross-sectional international registry[J].Heart,2012,98(3):195

220 Cosio FG,Aliot E,Botto GL,et al.Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences:reasons for change to active antiarrhythmic treatment at the time of the first detected episode[J].Europace,2008,10(1):21

221 Van Gelder IC,Haegeli LM,Brandes A,et al.Rationale and current perspective for early rhythm control therapy in atrial fibrillation[J].Europace,2011,13(11):1 517

222 de Vos CB,Pisters R,Nieuwlaat R,et al.Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis[J].J Am Coll Cardiol,2010,55(8):725

223 Wijffels MC,Kirchhof CJ,Dorland R,et al.Atrial fibrillation begets atrial fibrillation.A study in awake chronically instrumented goats[J].Circulation,1995,92(7):1 954

224 Singh BN,Singh SN,Reda DJ,et al.Amiodarone versus sotalol for atrial fibrillation[J].N Engl J Med,2005,352(18):1 861

225 Airaksinen KE,Gronberg T,Nuotio I,et al.Thromboembolic complications after cardioversion of acute atrial fibrillation:the Fin CV(Finnish CardioV ersion)study[J].J Am Coll Cardiol,2013,62(13):1 187

226 Bermudez-Canete R,Santoro G,Bialkowsky J,et al.Patent ductus arteriosus occlusion using detachable coils[J].Am J Cardiol,1998,82(12):1 547

227 Weigner MJ,Caulfield TA,Danias PG,et al.Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours[J].Ann Intern Med,1997,126(8):615

228 Prystowsky EN,Benson DW,Fuster V,et al.Management of patients with atrial fibrillation.A Statement for Healthcare Professionals.From the Subcommittee on Electrocardiography and Electrophysiology,American Heart Association[J].Circulation,1996,93(6):1 262

229 Jaber WA,Prior DL,Thamilarasan M,et al.Efficacy of anticoagulation in resolving left atrial and left atrial appendage thrombi:A transesophageal echocardiographic study[J].Am Heart J,2000,140(1):150

230 You JJ,Singer DE,Howard PA,et al.Antithrombotic therapy for atrial fibrillation:Antithrombotic Therapy and Prevention of Thrombosis,9th ed:American College of Chest Physicians EvidenceBased Clinical Practice Guidelines[J].Chest,2012,141(2 Suppl):e531S

231 Flaker G,Lopes RD,Al-Khatib SM,et al.Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation:insights from the ARISTOTLE Trial(Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation)[J].J Am Coll Cardiol,2014,63(11):1 082

232 Nagarakanti R,Ezekowitz MD,Oldgren J,et al.Dabigatran versus warfarin in patients with atrial fibrillation:an analysis of patients undergoing cardioversion[J].Circulation,2011,123(2):131

233 Piccini JP,Stevens SR,Lokhnygina Y,et al.Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial[J].J Am Coll Cardiol,2013,61(19):1 998

234 Cappato R,Ezekowitz MD,Klein AL,et al.Rivaroxaban vs.vitamin K antagonists for cardioversion in atrial fibrillation[J].Eur Heart J,2014,35(47):3 346

235 Wu LA,Chandrasekaran K,Friedman PA,et al.Safety of expedited anticoagulation in patients undergoing transesophageal echocardiographic-guided cardioversion[J].Am J Med,2006,119(2):142

236 Pritchett EL,Page RL,Carlson M,et al.Efficacy and safety of sustained-release propafenone(propafenone SR)for patients with atrial fibrillation[J].Am J Cardiol,2003,92(8):941

237 Gallagher MM,Guo XH,Poloniecki JD,et al.Initial energy setting,outcome and efficiency in direct current cardioversion of atrial fibrillation and flutter[J].J Am Coll Cardiol,2001,38(5):1498

238 Mittal S,Ayati S,Stein KM,et al.Transthoracic cardioversion of atrial fibrillation:comparison of rectilinear biphasic versus damped sine wave monophasic shocks[J].Circulation,2000,101(11):1282

239 Kirchhof P,Andresen D,Bosch R,et al.Short-term versus longterm antiarrhythmic drug treatment after cardioversion of atrial fibrillation(Flec-SL):a prospective,randomised,open-label,blinded endpoint assessment trial[J].Lancet,2012,380(9838):238

240 Bianconi L,Mennuni M,Lukic V,et al.Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation:a placebo-controlled study[J].J Am Coll Cardiol,1996,28(3):700

241 Oral H,Souza JJ,Michaud GF,et al.Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment[J].N Engl J Med,1999,340(24):1 849

242 Capucci A,Villani GQ,Aschieri D,et al.Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation[J].Eur Heart J,2000,21(1):66

243 Hiatt WR,Lincoff AM,Harrington RA.Acute pharmacological conversion of atrial fibrillation to sinus rhythm:is short-term symptomatic therapy worth it?A report from the December 2007 Meeting of the Cardiovascular and Renal Drugs Advisory Committee of the Food and Drug Administration[J].Circulation,2008,117(22):2 956

244 Friberg J,Gadsboll N.Intracardiac low-energy versus transthoracic high-energy direct-current cardioversion of atrial fibrillation:a randomised comparison[J].Cardiology,2003,99(2):72

245 Levy S,Breithardt G,Campbell RW,et al.Atrial fibrillation:current knowledge and recommendations for management.Working Group on Arrhythmias of the European Society of Cardiology[J].Eur Heart J,1998,19(9):1 294

246 Schmitt C,Alt E,Plewan A,et al.Low energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation[J].J Am Coll Cardiol,1996,28(4):994

247 Letelier LM,Udol K,Ena J,et al.Effectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm:a meta-analysis[J].Arch Intern Med,2003,163(7):777

248 Khan IA,Mehta NJ,Gowda RM.Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation[J].Int J Cardiol,2003,89(2-3):239

249 Alboni P,Botto GL,Baldi N,et al.Outpatient treatment of recent-onset atrial fibrillation with the"pill-in-the-pocket"approach[J].N Engl J Med,2004,351(23):2 384

250 Khan IA.Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation[J].J Am Coll Cardiol,2001,37(2):542

251 Hilleman DE,Hunter CB,Mohiuddin SM,et al.Pharmacological management of atrial fibrillation following cardiac surgery[J].Am J Cardiovasc Drugs,2005,5(6):361

252 Ellenbogen KA,Clemo HF,Stambler BS,et al.Efficacy of ibutilide for termination of atrial fibrillation and flutter[J].Am J Cardiol,1996,78(8A):42

253 Stambler BS,Wood MA,Ellenbogen KA,et al.Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation.Ibutilide Repeat Dose Study Investigators[J].Circulation,1996,94(7):1 613

254 Patsilinakos S,Christou A,Kafkas N,et al.Effect of high doses of magnesium on converting ibutilide to a safe and more effective agent[J].Am J Cardiol,2010,106(5):673

255 Murray KT.Ibutilide[J].Circulation,1998,97(5):493

256 Kowey PR,Dorian P,Mitchell LB,et al.Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery:a randomized,double-blind,placebo-controlled trial[J].Circ Arrhythm Electrophysiol,2009,2(6):652

257 Roy D,Rowe BH,Stiell IG,et al.A randomized,controlled trial of RSD1235,a novel anti-arrhythmic agent,in the treatment of recent onset atrial fibrillation[J].J Am Coll Cardiol,2004,44(12):2 355

258 Camm AJ,Capucci A,Hohnloser SH,et al.A randomized activecontrolled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation[J].J Am Coll Cardiol,2011,57(3):313

259 Roy D,Pratt CM,Torp-Pedersen C,et al.Vernakalant hydrochloride for rapid conversion of atrial fibrillation:a phase 3,randomized,placebo-controlled trial[J].Circulation,2008,117(12):1518

260 Stiell IG,Roos JS,Kavanagh KM,et al.A multicenter,open-label study of vernakalant for the conversion of atrial fibrillation to sinus rhythm[J].Am Heart J,2010,159(6):1 095

261 Hohnloser SH,Crijns HJ,van Eickels M,et al.Effect of dronedarone on cardiovascular events in atrial fibrillation[J].N Engl J Med,2009,360(7):668

262 Plewan A,Lehmann G,Ndrepepa G,et al.Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation;sotalol vs bisoprolol[J].Eur Heart J,2001,22(16):1 504

263 Di Benedetto S.Quinidine versus propafenone for conversion of atrial fibrillation to sinus rhythm[J].Am J Cardiol,1997,80(4):518

264 Pedersen OD,Bagger H,Keller N,et al.Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function:a Danish investigations of arrhythmia and mortality on dofetilide(diamond)substudy[J].Circulation,2001,104(3):292

265 Wang AH,Pu JL,Qi XY,et al.Evaluation of shensongyangxin capsules in the treatment of paroxysmal atrial fibrillation:a randomized,double-blind and controlled multicenter trial[J].Zhonghua Yi Xue Zazhi,2011,91(24):1 677

266 Chen Y,Nie S,Gao H,et al.The effects of wenxin keli on p-wave dispersion and maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation:a meta-analysis of randomized controlled trials[J].Evid Based Complement Alternat Med,2013,ID:dx.doi.org/10.1155/2013/245958

267 Calkins H,Brugada J,Packer DL,et al.HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation:Recommendations for personnel,policy,procedures and follow-up[J].Heart Rhythm,2007,4(6):816

268 Calkins H,Kuck KH,Cappato R,et al.2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation:recommendations for patient selection,procedural techniques,patient management and follow-up,definitions,endpoints,and research trial design[J].Europace,2012,14(4):528

269 Wann LS,Curtis AB,January CT,et al.2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation(updating the 2006 guideline).a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J].Heart Rhythm,2011,8(1):157

270 Verma A,Macle L,Cox J,et al.Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010:catheter ablation for atrial fibrillation/atrial flutter[J].Can J Cardiol,2011,27(1):60

271 Gillis AM,Verma A,Talajic M,et al.Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010:rate and rhythm management[J].Can J Cardiol,2011,27(1):47

272 Camm AJ,Kirchhof P,Lip GYH,et al.Guidelines for the management of atrial fibrillation.The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology(ESC)[J].Eur Heart J,2010,31(19):2 369

273 黄从新,张澍,马长生,等.心房颤动:目前的认识和治疗建议—2012[J].中华心律失常学杂志,2012,6(4):246

274 Wasmer K,Eckardt L.Management of atrial fibrillation around the world:a comparison of current ACCF/AHA/HRS,CCS,and ESC guidelines[J].Europace,2011,13(10):1 368

275 Callans DJ.Apples and oranges comparing antiarrhythmic drugs and catheter ablation for treatment of atrial fibrillation[J].Circulation,2008,118(24):2 488

276 Jais P,Cauchemez B,Macle L,et al.Catheter ablation versus antiarrhythmic drugs for atrial fibrillation The A4 Study[J].Circulation,2008,118(24):2 498

277 Oral H,Pappone C,Chugh A,et al.Circumferential pulmonaryvein ablation for chronic atrial fibrillation[J].N Engl J Med,2006,354(9):934

278 Pappone C,Augello G,Sala S,et al.A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation:the APAF study[J].J Am Coll Cardiol,2006,48(11):2 340

279 Stabile G,Bertaglia E,Senatore G,et al.Catheter ablation treatment in patients with drug-refractory atrial fibrillation:a prospective,multi-centre,randomized,controlled study(Catheter Ablation For The Cure of Atrial Fibrillation Study)[J].Eur Heart J,2006,27(2):216

280 Wazni OM,Marrouche NF,Martin DO,et al.Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation:a randomized trial[J].JAMA-J Am Med Assoc,2005,293(21):2 634

281 Wilber DJ,Pappone C,Neuzil P,et al.Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation:A Randomized Controlled Trial[J].JAMA-J Am Med Assoc,2010,303(4):333

282 Piccini JP,Lopes RD,Kong MH,et al.Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation:a meta-analysis of randomized,controlled trials[J].Circ-Arrhythmia Electrophysiol,2009,2(6):626

283 Morillo CA,Verma A,Connolly SJ,et al.Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation(RAAFT-2):A Randomized Trial[J].JAMA-J Am Med Assoc,2014,311(7):692

284 Nielsen JC,Johannessen A,Raatikainen P,et al.Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation[J].N Engl J Med,2012,367(17):1 587

285 Mont L,Bisbal F,Hernandez-Madrid A,et al.Catheter ablation vs.antiarrhythmic drug treatment of persistent atrial fibrillation:a multicentre,randomized,controlled trial(SARA study)[J].Eur Heart J,2014,35(8):501

286 Parkash R,Tang ASL,Sapp JL,et al.Approach to the catheter ablation technique of paroxysmal and persistent atrial fibrillation:a meta-analysis of the randomized controlled trials[J].J Cardiovasc Electrophysiol,2011,22(7):729

287 Earley MJ,Abrams DJR,Staniforth AD,et al.Catheter ablation of permanent atrial fibrillation:medium term results[J].Heart,2006,92(2):233

288 Haissaguerre M,Jais P,Shah DC,et al.Catheter ablation of chronic atrial fibrillation targeting the reinitiating triggers[J].J Cardiovasc Electrophysiol,2000,11(1):2

289 Haissaguerre MHR,Hocini M,Sanders P,et al.Catheter ablation of long-lasting persistent atrial fibrillation:Clinical outcome and mechanisms of subsequent arrhythmias[J].J Cardiovasc Electrophysiol,2005,16(11):1 138

290 Oral H,Chugh A,Good E,et al.Radiofrequency catheter ablation of chronic atrial fibrillation guided by complex electrograms[J].Circulation,2007,115(20):2 606

291 Pappone C,Oreto G,Rosanio S,et al.Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation-Efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation[J].Circulation,2001,104(21):2 539

292 Sanders P,Hocini M,Jais P,et al.Complete isolation of the pulmonary veins and posterior left atrium in chronic atrial fibrillation.Long-term clinical outcome[J].Eur Heart J,2007,28(15):1862

293 Chen MS,Marrouche NF,Khaykin Y,et al.Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function[J].J Am Coll Cardiol,2004,43(6):1 004

294 Hsu LF,Jais P,Sanders P,et al.Catheter ablation for atrial fibrillation in congestive heart failure[J].N Engl J Med,2004,351(23):2 373

295 Khaykin Y,Marrouche NF,Saliba W,et al.Pulmonary vein antrum isolation for treatment of atrial fibrillation in patients with valvular heart disease or prior open heart surgery[J].Heart Rhythm,2004,1(1):33

296 Lang CC,Santinelli V,Augello G,et al.Transcatheter radiofrequency ablation of atrial fibrillation in patients with mitral valve prostheses and enlarged atria:Safety,feasibility,and efficacy[J].J Am Coll Cardiol,2005,45(6):868

297 Nedios S,Sommer P,Dagres N,et al.Long-term follow-up after atrial fibrillation ablation in patients with impaired left ventricular systolic function:the importance of rhythm and rate control[J].Heart Rhythm,2014,11(3):344

298 Wang X,Liu X,Shi H,et al.Pulmonary vein isolation combined with substrate modification for persistent atrial fibrillation treatment in patients with valvular heart diseases[J].Heart,2009,95(21):1 773

299 Cha YM,Wokhlu A,Asirvatham SJ,et al.Success of ablation for atrial fibrillation in isolated left ventricular diastolic dysfunction.a comparison to systolic dysfunction and normal ventricular function[J].Circ-Arrhythmia Electrophysiol,2011,4(5):724

300 Wilton SB,Fundytus A,Ghali WA,et al.Meta-analysis of the effectiveness and safety of catheter ablation of atrial fibrillation in patients with versus without left ventricular systolic dysfunction[J].Am J Cardiol,2010,106(9):1 284

301 Jiang H,Lu ZB,Lei HD,et al.Predictors of early recurrence and delayed cure after segmental pulmonary vein isolation for paroxysmal atrial fibrillation without structural heart disease[J].J Interv Card Electrophysiol,2006,15(3):157

302 Cappato R,Calkins H,Chen SA,et al.Updated worldwide survey on the methods,efficacy,and safety of catheter ablation for human atrial fibrillation[J].Circ-Arrhythmia Electrophysiol,2010,3(1):32

303 Cappato R,Calkins H,Chen SA,et al.Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation[J].J Am Coll Cardiol,2009,53(19):1 798

304 Belhassen B.A 1 Per 1,000 mortality rate after catheter ablation of atrial fibrillation:an acceptable risk[J]?J Am Coll Cardiol,2009,53(19):1 804

305 Haissaguerre M,Shah DC,Jais P,et al.Electrophysiological breakthroughs from the left atrium to the pulmonary veins[J].Circulation,2000,102(20):2 463

306 Sicouri S,Charles A.Pulmonary vein sleeves as a pharmacologic model for the study of atrial fibrillation[J].Electrofisiol Arritm,2010,3(4):108

307 Essebag V,Wylie J V,Reynolds MR,et al.Bi-directional electrical pulmonary vein isolation as an endpoint for ablation of paroxysmal atrial fibrillation[J].J Interv Card Electrophysiol,2006,17(2):111

308 Tada H,Naito S,Kurosaki K,et al.Segmental pulmonary vein isolation for paroxysmal atrial fibrillation improves quality of life and clinical outcomes[J].Circ J,2003,67(10):861

309 杨延宗,刘少稳,高连君,等.射频导管消融进行心房肺静脉/或上腔静脉电隔离治疗阵发性心房颤动[J].中华心律失常学杂志,2003,7:292

310 黄从新,张澍,马长生,等.中国经导管消融治疗心房颤动注册研究[J].中华心律失常学杂志,2006,10(6):468

311 Sawhney N,Anousheh R,Chen WC,et al.Five-year outcomes after segmental pulmonary vein isolation for paroxysmal atrial fibrillation[J].Am J Cardiol,2009,104(3):366

312 Lim TW,Jassal IS,Ross DL,et al.Medium-term efficacy of segmental ostial pulmonary vein isolation for the treatment of permanent and persistent atrial fibrillation[J].Pacing Clin Electrophysiol,2006,29(4):374

313 Arentz T,Jander N,von Rosenthal J,et al.Incidence of pulmonary vein stenosis 2 years after radiofrequency catheter ablation of refractory atrial fibrillation[J].Eur Heart J,2003,24(10):963

314 Dong YX,Gao LJ,Zhang SL,et al.Pulmonary vein occlusion and remodeling after electrical isolation treatment for atrial fibrillation:a case report[J].Chin Med J(Engl),2005,118(14):1 225

315 Schmidt M,Dorwarth U,Andresen D,et al.Cryoballoon versus RF ablation in paroxysmal atrial fibrillation:results from the German Ablation Registry[J].J Cardiovasc Electrophysiol,2014,25(1):1

316 Aryana A,Morkoch S,Bailey S,et al.Acute procedural and cryoballoon characteristics from cryoablation of atrial fibrillation using the first-and second-generation cryoballoon:a retrospective comparative study with follow-up outcomes[J].J Interv Card Electrophysiol,2014,41(2):177

317 Ouyang F,Bansch D,Ernst S,et al.Complete isolation of left atrium surrounding the pulmonary veins:new insights from the double-Lasso technique in paroxysmal atrial fibrillation[J].Circulation,2004,110(15):2 090

318 Hocini M,Sanders P,Jais P,et al.Techniques for curative treatment of atrial fibrillation[J].J Cardiovasc Electrophysiol,2004,15(12):1 467

319 Augello G,Vicedomini G,Saviano M,et al.Pulmonary vein isolation after circumferential pulmonary vein ablation:comparison between Lasso and three-dimensional electroanatomical assessment of complete electrical disconnection[J].Heart Rhythm,2009,6(12):1 706

320 Marrouche NF,Martin DO,Wazni O,et al.Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation:impact on outcome and complications[J].Circulation,2003,107(21):2 710

321 Earley MJ,Showkathali R,Alzetani M,et al.Radiofrequency ablation of arrhythmias guided by non-fluoroscopic catheter location:a prospective randomized trial[J].Eur Heart J,2006,27(10):1223

322 Finlay MC,Hunter RJ,Baker V,et al.A randomised comparison of Cartomerge vs.NavX fusion in the catheter ablation of atrial fibrillation:the CAVERN Trial[J].J Interv Card Electrophysiol,2012,33(2):161

323 Lin YJ,Chang SL,Lo LW,et al.A prospective and randomized comparison of limited versus extensive atrial substrate modification after circumferential pulmonary vein isolation in nonparoxysmal atrial fibrillation[J].J Cardiovasc Electrophysiol,2014,25(8):803

324 Proietti R,Santangeli P,Di Biase L,et al.Comparative effectiveness of wide antral versus ostial pulmonary vein isolation:a systematic review and meta-analysis[J].Circ Arrhythm Electrophysiol,2014,7(1):39

325 Lo LW,Tai CT,Lin YJ,et al.Mechanisms of recurrent atrial fibrillation:comparisons between segmental ostial versus circumferential pulmonary vein isolation[J].J Cardiovasc Electrophysiol,2007,18(8):803

326 Tamborero D,Mont L,Nava S,et al.Incidence of pulmonary vein stenosis in patients submitted to atrial fibrillation ablation:a comparison of the selective segmental ostial ablation vs the circumferential pulmonary veins ablation[J].J Interv Card Electrophysiol,2005,14(1):21

327 Tilz RR,Chun KR,Schmidt B,et al.Catheter ablation of longstanding persistent atrial fibrillation:a lesson from circumferential pulmonary vein isolation[J].J Cardiovasc Electrophysiol,2010,21(10):1 085

328 Haissaguerre M,Sanders P,Hocini M,et al.Catheter ablation of long-lasting persistent atrial fibrillation:critical structures for termination[J].J Cardiovasc Electrophysiol,2005,16(11):1 125

329 Knecht S,Hocini M,Wright M,et al.Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation[J].Eur Heart J,2008,29(19):2 359

330 Raviele A,Themistoclakis S,Rossillo A,et al.Iatrogenic postatrial fibrillation ablation left atrial tachycardia/flutter:how to prevent and treat it[J]?J Cardiovasc Electrophysiol,2005,16(3):298

331 Ouyang F,Ernst S,Vogtmann T,et al.Characterization of reentrant circuits in left atrial macroreentrant tachycardia:critical isthmus block can prevent atrial tachycardia recurrence[J].Circulation,2002,105(16):1 934

332 O'Neill L,Hensey M,Nolan W,et al.Clinical outcome when left atrial posterior wall box isolation is included as a catheter ablation strategy in patients with persistent atrial fibrillation[J].J Interv Card Electrophysiol,2015,44(1):63

333 Tamborero D,Mont L,Berruezo A,et al.Left atrial posterior wall isolation does not improve the outcome of circumferential pulmonary vein ablation for atrial fibrillation:a prospective randomized study[J].Circ Arrhythm Electrophysiol,2009,2(1):35

334 Sawhney N,Anousheh R,Chen W,et al.Circumferential pulmonary vein ablation with additional linear ablation results in an increased incidence of left atrial flutter compared with segmental pulmonary vein isolation as an initial approach to ablation of paroxysmal atrial fibrillation[J].Circ Arrhythm Electrophysiol,2010,3(3):243

335 Nademanee K,McK enzie J,Kosar E,et al.A new approach for catheter ablation of atrial fibrillation:mapping of the electrophysiologic substrate[J].J Am Coll Cardiol,2004,43(11):2 044

336 You DJ,Chang D,Zhang SL,et al.Substrate of complex fractionated atrial electrograms:evidence by pathologic analysis[J].Chin Med J(Engl),2012,125(24):4 393

337 Zhang SL,Dong YX,Jiang P,et al.Effect of ablation of complex fractionated atrial electrogram on vagal modulation in dogs[J].Chin Med J(Engl),2010,123(22):3 288

338 Verma A,Mantovan R,Macle L,et al.Substrate and Trigger Ablation for Reduction of Atrial Fibrillation(STAR AF):a randomized,multicentre,international trial[J].Eur Heart J,2010,31(11):1 344

339 Hayward RM,Upadhyay GA,Mela T,et al.Pulmonary vein isolation with complex fractionated atrial electrogram ablation for paroxysmal and nonparoxysmal atrial fibrillation:a meta-analysis[J].Heart Rhythm,2011,8(7):994

340 Li WJ,Bai YY,Zhang HY,et al.Additional ablation of complex fractionated atrial electrograms after pulmonary vein isolation in patients with atrial fibrillation:a meta-analysis[J].Circ Arrhythm Electrophysiol,2011,4(2):143

341 Pokushalov E,Romanov A,Artyomenko S,et al.Left atrial ablation at the anatomic areas of ganglionated plexi for paroxysmal atrial fibrillation[J].Pacing Clin Electrophysiol,2010,33(10):1 231

342 Mikhaylov E,Kanidieva A,Sviridova N,et al.Outcome of anatomic ganglionated plexi ablation to treat paroxysmal atrial fibrillation:a 3-year follow-up study[J].Europace,2011,13(3):362

343 Pokushalov E,Romanov A,Katritsis DG,et al.Ganglionated plexus ablation vs linear ablation in patients undergoing pulmonary vein isolation for persistent/long-standing persistent atrial fibrillation:a randomized comparison[J].Heart Rhythm,2013,10(9):1 280

344 Scherlag BJ,Nakagawa H,Jackman WM,et al.Electrical stimulation to identify neural elements on the heart:their role in atrial fibrillation[J].J Interv Card Electrophysiol,2005,13(Suppl 1):37

345 Narayan SM,Baykaner T,Clopton P,et al.Ablation of rotor and focal sources reduces late recurrence of atrial fibrillation compared with trigger ablation alone:extended follow-up of the CONFIRM trial(Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation)[J].J Am Coll Cardiol,2014,63(17):1 761

346 Narayan SM,Krummen DE,Clopton P,et al.Direct or coincidental elimination of stable rotors or focal sources may explain successful atrial fibrillation ablation:on-treatment analysis of the CONFIRM trial(Conventional ablation for AF with or without focal impulse and rotor modulation)[J].J Am Coll Cardiol,2013,62(2):138

347 Narayan SM,Krummen DE,Shivkumar K,et al.Treatment of atrial fibrillation by the ablation of localized sources:CONFIRM(Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation)trial[J].J Am Coll Cardiol,2012,60(7):628

348 Miller JM,Kowal RC,Swarup V,et al.Initial independent outcomes from focal impulse and rotor modulation ablation for atrial fibrillation:multicenter FIRM registry[J].J Cardiovasc Electrophysiol,2014,25(9):921

349 O'Neill MD,Jais P,Takahashi Y,et al.The stepwise ablation approach for chronic atrial fibrillation--evidence for a cumulative effect[J].J Interv Card Electrophysiol,2006,16(3):153

350 O'Neill MD,Wright M,Knecht S,et al.Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint[J].Eur Heart J,2009,30(9):1 105

351 Scherr D,Khairy P,Miyazaki S,et al.Five-year outcome of catheter ablation of persistent atrial fibrillation using termination of atrial fibrillation as a procedural endpoint[J].Circ Arrhythm Electrophysiol,2015,8(1):18

352 Faustino M,Pizzi C,Capuzzi D,et al.Impact of atrial fibrillation termination mode during catheter ablation procedure on maintenance of sinus rhythm[J].Heart Rhythm,2014,11(9):1 528

353 Elayi CS,Di Biase L,Barrett C,et al.Atrial fibrillation termination as a procedural endpoint during ablation in long-standing persistent atrial fibrillation[J].Heart Rhythm,2010,7(9):1 216

354 Khan A,Mittal S,Kamath GS,et al.Pulmonary vein isolation alone in patients with persistent atrial fibrillation:an ablation strategy facilitated by antiarrhythmic drug induced reverse remodeling[J].J Cardiovasc Electrophysiol,2011,22(2):142

355 Rivard L,Hocini M,Rostock T,et al.Improved outcome following restoration of sinus rhythm prior to catheter ablation of persistent atrial fibrillation:a comparative multicenter study[J].Heart Rhythm,2012,9(7):1 025

356 Jiang CY,Jiang RH,Matsuo S,et al.Earyly detection of pulmonary vein reconnection after isolation in patients with paroxysmal atrial fibrillation:a comparison of ATP-induction and reassessment at30 minutes postiolation[J].J Cardiovasc Electrophysiol,2009,20(12):1 382

357 Essebag V,Baldessin F,Reynolds MR,et al.Non-inducibility post-pulmonary vein isolation achieving exit block predicts freedom from atrial fibrillation[J].Eur Heart J,2005,26(23):2 550

358 Calkins H,Kuck KH,Cappato R,et al.2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation:recommendations for patient selection,procedural techniques,patient management and follow-up,definitions,endpoints,and research trial design.A report of the Heart Rhythm Society(HRS)Task Force on Catheter and Surgical Ablation of Atrial Fibrillation.Developed in partnership with the European Heart Rhythm Association(EHRA),a registered branch of the European Society of Cardiology(ESC)and the European Cardiac Arrhythmia Society(ECAS);and in collaboration with the American College of Cardiology(ACC),American Heart Association(AHA),the Asia Pacific Heart Rhythm Society(APHRS),and the Society of Thoracic Surgeons(STS).Endorsed by the governing bodies of the American College of Cardiology Foundation,the American Heart Association,the European Cardiac Arrhythmia Society,the European Heart Rhythm Association,the Society of Thoracic Surgeons,the Asia Pacific Heart Rhythm Society,and the Heart Rhythm Society[J].Heart Rhythm,2012,9(4):632

359 Andrade JG,Dubuc M,Guerra PG,et al.The Biophysics and biomechanics of cryoballoon ablation[J].Pacing Clin Electrophysiol,2012,35(9):1 162

360 凌天佑,吴立群.采用冷冻球囊消融治疗心房颤动的研究状况[J].中国心脏起搏与心电生理杂志,2014,28:270

361 Packer DL,Kowal RC,Wheelan KR,et al.Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation first results of the North American Arctic Front(STOP AF)Pivotal Trial[J].JAm Coll Cardiol,2013,61(16):1 713

362 Knight BP NP,Sangrigoli R,Essebag V,et al.12-month clinical outcomes following pulmonary vein isolation(pvi)using the arctic front advance cryoballoon:Interim results from the stop-af post approval study[abstract][J].HRS May 2015.Boston,MA

363 Furnkranz A,Brugada J,Albenque JP,et al.Rationale and design of FIRE AND ICE:A multicenter randomized trial comparing efficacy and safety of pulmonary vein isolation using a cryoballoon versus radiofrequency ablation with 3D-reconstruction[J].J Cardiovasc Electrophysiol,2014,25(12):1 314

364 Su W,Kowal R,Kowalski M,et al.Best practice guide for cryoballoon ablation in atrial fibrillation:the compilation experience of more than 3000 procedures[J].Heart Rhythm,2015,12(7):1658

365 Neven K,Schmidt B,Metzner A,et al.Fatal end of a safety algorithm for pulmonary vein isolation with use of high-intensity focused ultrasound[J].Circ-Arrhythmia Electrophysiol,2010,3(3):260

366 Metzner A,Schmidt B,Fuernkranz A,et al.One-year clinical outcome after pulmonary vein isolation using the novel endoscopic ablation system in patients with paroxysmal atrial fibrillation[J].Heart Rhythm,2011,8(7):988

367 Puwanant S,Varr BC,Shrestha K,et al.Role of the CHADS(2)score in the evaluation of thromboembolic risk in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation[J].J Am Coll Cardiol,2009,54(22):2032

368 Scherr D,Dalal D,Chilukuri K,et al.Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation[J].J Cardiovasc Electrophysiol,2009,20(4):379

369 Dong J,Calkins H,Solomon SB,et al.Integrated electroanatomic mapping with three-dimensional computed tomographic images for real-time guided ablations[J].Circulation,2006,113(2):186

370 喻荣辉,马长生,董建增,等.电解剖标测和磁共振影像融合技术指导导管消融心房颤动的有效性研究[J].中华心血管病杂志,2007,35(11):1 029

371 Kwak JJ,Pak HN,Jang JK,et al.Safety and convenience of continuous warfarin strategy during the periprocedural period in patients who underwent catheter ablation of atrial fibrillation[J].J Cardiovasc Electrophysiol,2010,21(6):620

372 Wazni OM,Beheiry S,Fahmy T,et al.Atrial fibrillation ablation in patients with therapeutic international normalized ratio——Comparison of strategies of anticoagulation management in the periprocedural period[J].Circulation,2007,116(22):2 531

373 Bassiouny M,Saliba W,Rickard J,et al.Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation[J].Circ-Arrhythmia Electrophysiol,2013,6(3):460

374 Kim JS,She F,Jongnarangsin K,et al.Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation[J].Heart Rhythm,2013,10(4):483

375 龙德勇,刘兴鹏,马长生,等.心房颤动射频消融术中应用丙泊酚深度镇静的临床观察[J].中华心律失常学杂志,2006,10(5):338

376 Sairaku A,Yoshida Y,Hirayama H,et al.Procedural sedation with dexmedetomidine during ablation of atrial fibrillation:a randomized controlled trial[J].Europace,2014,16(7):994

377 Kottkamp H,Hindricks G,Eitel C,et al.Deep sedation for catheter ablation of atrial fibrillation:a prospective study in 650 consecutive patients[J].J Cardiovasc Electrophysiol,2011,22(12):1339

378 Bubien RS,Fisher JD,Gentzel JA,et al.NASPE expert consensus document:use of i.v.(conscious)sedation/analgesia by nonanesthesia personnel in patients undergoing arrhythmia specific diagnostic,therapeutic,and surgical procedures[J].Pacing Clin Electrophysiol,1998,21(2):375

379 Maleki K,Mohammadi R,Hart D,et al.Intracardiac ultrasound detection of thrombus on transseptal sheath:Incidence,treatment,and prevention[J].J Cardiovasc Electrophysiol,2005,16(6):561

380 Ren JF,Marchlinski FE,Callans DJ.Left atrial thrombus associated with ablation for atrial fibrillation:identification with intracardiac echocardiography[J].J Am Coll Cardiol,2004,43(10):1861

381 Wazni OM,Rossillo A,Marrouche NF,et al.Embolic events and char formation during pulmonary vein isolation in patients with atrial fibrillation:Impact of different anticoagulation regimens and importance of intracardiac echo imaging[J].J Cardiovasc Electrophysiol,2005,16(6):576

382 Gautam S,John RM,Stevenson WG,et al.Effect of therapeutic INR on activated clotting times,heparin dosage,and bleeding risk during ablation of atrial fibrillation[J].J Cardiovasc Electrophysiol,2011,22(3):248

383 Martinek M,Bencsik G,Aichinger J,et al.Esophageal damage during radiofrequency ablation of atrial fibrillation:impact of energy settings,lesion sets,and esophageal visualization[J].J Cardiovasc Electrophysiol,2009,20(7):726

384 Hindricks G,Piorkowski C,Tanner H,et al.Perception of atrial fibrillation before and after radiofrequency catheter ablation-Relevance of asymptomatic arrhythmia recurrence[J].Circulation,2005,112(3):307

385 Klemm HU,Ventura R,Rostock T,et al.Correlation of symptoms to ECG diagnosis following atrial fibrillation ablation[J].J Cardiovasc Electrophysiol,2006,17(2):146

386 Kottkamp H,Tanner H,Kobza R,et al.Time courses and quantitative analysis of atrial fibrillation episode number and duration after circular plus linear left atrial lesions-trigger elimination or substrate modification:Early or delayed cure?[J].J Am Coll Cardiol,2004,44(4):869

387 Oral H,Veerareddy S,Good E,et al.Prevalence of asymptomatic recurrences of atrial fibrillation after successful radiofrequency catheter ablation[J].J Cardiovasc Electrophysiol,2004,15(8):920

388 Pokushalov E,Romanov A,Corbucci G,et al.Ablation of paroxysmal and persistent atrial fibrillation:1-year follow-up through continuous subcutaneous monitoring[J].J Cardiovasc Electrophysiol,2011,22(4):369

389 Senatore G,Stabile G,Bertaglia E,et al.Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation[J].J Am Coll Cardiol,2005,45(6):873

390 Vasamreddy CR,Dalal D,Dong J,et al.Symptomatic and asymptomatic atrial fibrillation in patients undergoing radiofrequency catheter ablation[J].J Cardiovasc Electrophysiol,2006,17(2):134

391 Purerfellner H,Gillis AM,Holbrook R,et al.Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies[J].Pacing Clin Electrophysiol,2004,27(7):983

392 Seidl K,Meisel E,Van Agt E,et al.Is the atrial high rate episode diagnostic feature reliable in detecting paroxysmal episodes of atrial tachyarrhythmias[J]?Pacing Clin Electrophysiol,1998,21(4 Pt1):694

393 Eitel C,Husser D,Hindricks G,et al.Performance of an implantable automatic atrial fibrillation detection device:impact of software adjustments and relevance of manual episode analysis[J].Europace,2011,13(4):480

394 Hindricks G,Pokushalov E,Urban L,et al.Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation results of the XPECT Trial[J].Circ-Arrhythmia Electrophysiol,2010,3(2):141

395 Bertaglia E,Stabile G,Senatore G,et al.Predictive value of early atrial tachyarrhythmias recurrence after circumferential anatomical pulmonary vein ablation[J].Pacing Clin Electrophysiol,2005,28(5):366

396 Vasamreddy CR,Lickfett L,Jayam VK,et al.Predictors of recurrence following catheter ablation of atrial fibrillation using an irrigated-tip ablation catheter[J].J Cardiovasc Electrophysiol,2004,15(6):692

397 Oral H,Knight BP,Ozaydin M,et al.Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation[J].J Am Coll Cardiol,2002,40(1):100

398 Leong-Sit P,Roux JF,Zado E,et al.Antiarrhythmics after ablation of atrial fibrillation(5A Study)six-month follow-up study[J].Circ-Arrhythmia Electrophysiol,2011,4(1):11

399 Chilukuri K,Dukes J,Dalal D,et al.Outcomes in patients requiring cardioversion following catheter ablation of atrial fibrillation[J].J Cardiovasc Electrophysiol,2010,21(1):27

400 Ouyang F,Tilz R,Chun J,et al.Long-term results of catheter ablation in paroxysmal atrial fibrillation lessons from a 5-year followup[J].Circulation,2010,122(23):2 368

401 Tzou WS,Marchlinski FE,Zado ES,et al.Long-term outcome after successful catheter ablation of atrial fibrillation[J].Circ-Arrhythmia Electrophysiol,2010,3(3):237

402 Weerasooriya R,Khairy P,Litalien J,et al.Catheter ablation for atrial fibrillation are results maintained at 5 years of follow-up[J]?J Am Coll Cardiol,2011,57(2):160

403 Arbelo E,Brugada J,Hindricks G,et al.ESC-EUR observational research programme:the atrial fibrillation ablation pilot study,conducted by the European Heart Rhythm Association[J].Europace,2012,14(8):1 094

404 Verma A,Natale A.Why atrial fibrillation ablation should be con-sidered first-line therapy for some patients[J].Circulation,2005,112(8):1 214

405 Akca F,Janse P,Theuns D,et al.A prospective study on safety of catheter ablation procedures:Contact force guided ablation could reduce the risk of cardiac perforation[J].Int J Cardiol,2015,179:441

406 Kuwahara T,Takahashi A,Takahashi Y,et al.Clinical characteristics of massive air embolism complicating left atrial ablation of atrial fibrillation:lessons from five cases[J].Europace,2012,14(2):204

407 von Bary C,Weber S,Dornia C,et al.Evaluation of pulmonary vein stenosis after pulmonary vein isolation using a novel circular mapping and ablation catheter(PVAC)[J].Circ-Arrhythmia Electrophysiol,2011,4(5):630

408 Di Biase L,Fahmy TS,Wazni OM,et al.Pulmonary vein total occlusion following catheter ablation for atrial fibrillation——Clinical implications after long-term follow-up[J].J Am Coll Cardiol,2006,48(12):2 493

409 Packer DL,Keelan P,Munger TM,et al.Clinical presentation,investigation,and management of pulmonary vein stenosis complicating ablation for atrial fibrillation[J].Circulation,2005,111(5):546

410 Gerstenfeld EP.New technologies for catheter ablation of atrial fibrillation[J].Current Treatment Options in Cardiovascular Medicine,2011,13(5):393

411 Pappone C,Oral H,Santinelli V,et al.Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation[J].Circulation,2004,109(22):2 724

412 Scanavacca MI,Avila AD,Parga J,et al.Left atrial-esophageal fistula following radiofrequency catheter ablation of atrial fibrillation[J].J Cardiovasc Electrophysiol,2004,15(8):960

413 Aryana A,Singh SM,Kowalski M,et al.Acute and long-term outcomes of catheter ablation of atrial fibrillation using the secondgeneration cryoballoon versus open-irrigated radiofrequency:a multicenter experience[J].J Cardiovasc Electrophysiol,2015

414 Cheng XC,Hu QW,Zhou CY,et al.The long-term efficacy of cryoballoon vs irrigated radiofrequency ablation for the treatment of atrial fibrillation:a meta-analysis[J].Int J Cardiol,2015,181:297

415 Mugnai G,de Asmundis C,Ciconte G,et al.Incidence and characteristics of complications in the setting of second-generation cryoballoon ablation:a large single-center study of 500 consecutive patients[J].Heart Rhythm,2015,12(7):1 476

416 Sanchez-Quintana D,Ho SY,Climent V,et al.Anatomic evaluation of the left phrenic nerve relevant to epicardial and endocardial catheter ablation:implications for phrenic nerve injury[J].Heart Rhythm,2009,6(6):764

417 Sarabanda AV,Bunch TJ,Johnson SB,et al.Efficacy and safety of circumferential pulmonary vein isolation using a novel cryothermal balloon ablation system[J].J Am Coll Cardiol,2005,46(10):1 902

418 Kumar S,Barbhaiya CR,Baldinger SH,et al.Epicardial phrenic nerve displacement during catheter ablation of atrial and ventriculararrhythmias:procedural experience and outcomes[J].Circ Arrhythm Electrophysiol,2015,8(4):896

419 Santangeli P,Marchlinski FE.Left phrenic nerve pacing from the left subclavian vein novel method to monitor for left phrenic nerve injury during catheter ablation[J].Circ-Arrhythmia Electrophysiol,2015,8(1):241

420 Shah D,Dumonceau JM,Burri H,et al.Acute pyloric spasm and gastric hypomotility——an extracardiac adverse effect of percutaneous radiofrequency ablation for atrial fibrillation[J].J Am Coll Cardiol,2005,46(2):327

421 Takahashi Y,Jais P,Hocini M,et al.Acute occlusion of the left circumflex coronary artery during mitral isthmus linear ablation[J].J Cardiovasc Electrophysiol,2005,16(10):1 104

422 Tisi PV,Callam MJ.Treatment for femoral pseudoaneurysms[J].Cochrane Database Syst Rev,2009,(2):CD004 981

423 Carlson MD,Ip J,Messenger J,et al.A new pacemaker algorithm for the treatment of atrial fibrillation:results of the Atrial Dynamic Overdrive Pacing Trial(ADOPT)[J].J Am Coll Cardiol,2003,42(4):627

424 Purerfellner H,Ruiter JH,Widdershoven JW,et al.Reduction of atrial tachyarrhythmia episodes during the overdrive pacing period using the Post-Mode Switch Overdrive Pacing(PMOP)algorithm[J].Heart Rhythm,2006,3(10):1 164

425 Sulke N,Silberbauer J,Boodhoo L,et al.The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation:the Pacemaker Atrial Fibrillation Suppression(PAFS)study[J].Europace,2007,9(9):790

426 Epstein AE,Dimarco JP,Ellenbogen KA,et al.ACC/AHA/HRS2008 Guidelines for device-based therapy of cardiac rhythm abnormalities[J].Heart Rhythm,2008,5(6):e1-62

427 Gold MR,Adler S,Fauchier L,et al.Impact of atrial prevention pacing on atrial fibrillation burden:primary results of the Study of Atrial Fibrillation Reduction(SAFARI)trial[J].Heart Rhythm,2009,6(3):295

428 Padeletti L,Purerfellner H,Mont L,et al.New-generation atrial antitachycardia pacing(Reactive ATP)is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia:Results from the MINERVA randomized multicenter international trial[J].Heart Rhythm,2015,12(8):1 717

429 Connolly SJ,Kerr CR,Gent M,et al.Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes.Canadian Trial of Physiologic Pacing Investigators[J].N Engl J Med,2000,342(19):1 385

430 Lamas GA,Lee KL,Sweeney MO,et al.Ventricular pacing or dual-chamber pacing for sinus-node dysfunction[J].N Engl J Med,2002,346(24):1 854

431 Toff WD,Camm AJ,Skehan JD.Single-chamber versus dualchamber pacing for high-grade atrioventricular block[J].N Engl J Med,2005,353(2):145

432 Healey JS,Toff WD,Lamas GA,et al.Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing:meta-analysis of randomized trials,using individual patient data[J].Cir-culation,2006,114(1):11

433 Sweeney MO,Hellkamp AS,Ellenbogen KA,et al.Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction[J].Circulation,2003,107(23):2 932

434 Sweeney MO,Bank AJ,Nsah E,et al.Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease[J].N Engl J Med,2007,357(10):1 000

435 de Voogt WG,van Hemel NM,van de Bos AA,et al.Verification of pacemaker automatic mode switching for the detection of atrial fibrillation and atrial tachycardia with Holter recording[J].Europace,2006,8(11):950

436 Ziegler PD,Glotzer TV,Daoud EG,et al.Incidence of newly detected atrial arrhythmias via implantable devices in patients with a history of thromboembolic events[J].Stroke,2010,41(2):256

437 Glotzer TV,Hellkamp AS,Zimmerman J,et al.Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke:report of the Atrial Diagnostics Ancillary Study of the Mode Selection Trial(MOST)[J].Circulation,2003,107(12):1 614

438 Glotzer TV,Daoud EG,Wyse DG,et al.Rationale and design of a prospective study of the clinical significance of atrial arrhythmias detected by implanted device diagnostics:the TRENDS study[J].J Interv Card Electrophysiol,2006,15(1):9

439 Healey JS,Connolly SJ,Gold MR,et al.Subclinical atrial fibrillation and the risk of stroke[J].N Engl J Med,2012,366(2):120

440 Steven D,Rostock T,Lutomsky B,et al.What is the real atrial fibrillation burden after catheter ablation of atrial fibrillation?A prospective rhythm analysis in pacemaker patients with continuous atrial monitoring[J].Eur Heart J,2008,29(8):1 037

441 Gladstone D J,Spring M,Dorian P,et al.Atrial fibrillation in patients with cryptogenic stroke[J].N Engl J Med,2014,370(26):2 467

442 Williams JM,Ungerleider RM,Lofland GK,et al.Left atrial isolation:new technique for the treatment of supraventricular arrhythmias[J].J Thorac Cardiovasc Surg,1980,80(3):373

443 Guiraudon GM,Klein GJ,Sharma AD,et al.Surgical treatment of supraventricular tachycardia:a five-year experience[J].Pacing Clin Electrophysiol,1986,9(6 Pt 2):1 376

444 Smith PK,Holman WL,Cox JL.Surgical treatment of supraventricular tachyarrhythmias[J].The Surgical clinics of North America,1985,65(3):553

445 Cox JL.The surgical treatment of atrial fibrillation.IV.Surgical technique[J].J Thorac Cardiovasc Surg,1991,101(4):584

446 Cox JL,Schuessler RB,D'Agostino HJ,Jr,et al.The surgical treatment of atrial fibrillation.III.Development of a definitive surgical procedure[J].J Thorac Cardiovasc Surg,1991,101(4):569

447 Prasad SM,Maniar HS,Camillo CJ,et al.The Cox maze III procedure for atrial fibrillation:long-term efficacy in patients undergoing lone versus concomitant procedures[J].J Thorac Cardiovasc Surg,2003,126(6):1 822

448 Raanani E,Albage A,David TE,et al.The efficacy of the Cox/maze procedure combined with mitral valve surgery:a matched control study[J].Eur J Cardiothorac Surg,2001,19(4):438

449 Cox JL,Schuessler RB,Boineau JP.The development of the Maze procedure for the treatment of atrial fibrillation[J].Semin Thorac Cardiovasc Surg,2000,12(1):2

450 Damiano RJ,Gaynor SL,Bailey M,et al.The long-term outcome of patients with coronary disease and atrial fibrillation undergoing the Cox maze procedure[J].J Thorac Cardiovasc Surg,2003,126(6):2 016

451 Ad N,Henry L,Hunt S,et al.Do we increase the operative risk by adding the Cox Maze III procedure to aortic valve replacement and coronary artery bypass surgery?[J].J Thorac Cardiovasc Surg,2012,143(4):936

452 Jessurun ER,van Hemel NM,Defauw J,et al.Results of maze surgery for lone paroxysmal atrial fibrillation[J].Circulation,2000,101(13):1 559

453 Kim KC,Cho KR,Kim YJ,et al.Long-term results of the CoxMaze III procedure for persistent atrial fibrillation associated with rheumatic mitral valve disease:10-year experience[J].Eur J Cardiothorac Surg,2007,31(2):261

454 Bugge E,Nicholson IA,Thomas SP.Comparison of bipolar and unipolar radiofrequency ablation in an in vivo experimental model[J].Eur J Cardiothorac Surg,2005,28(1):76

455 Benussi S,Galanti A,Zerbi V,et al.Electrophysiologic efficacy of irrigated bipolar radiofrequency in the clinical setting[J].J Thorac Cardiovasc Surg,2010,139(5):1 131

456 Benussi S,Nascimbene S,Calori G,et al.Surgical ablation of atrial fibrillation with a novel bipolar radiofrequency device[J].J Thorac Cardiovasc Surg,2005,130(2):491

457 Gaynor SL,Diodato MD,Prasad SM,et al.A prospective,singlecenter clinical trial of a modified Cox maze procedure with bipolar radiofrequency ablation[J].J Thorac Cardiovasc Surg,2004,128(4):535

458 Miyairi T,Miura S,Kigawa I,et al.Mid-term results of a closed biatrial procedure using bipolar radiofrequency ablation concomitantly performed with non-mitral cardiac operations[J].Interactive cardiovascular and thoracic surgery,2009,9(2):169

459 崔永强,孟旭,李岩,等.干式双极射频消融手术治疗器质性心房颤动[J].中国医药,2010,5(6):522

460 王辉山,汪曾炜,李新民,等.141例心脏手术同期施行双极射频迷宫手术治疗心房颤动[J].中华胸心血管外科杂志,2009,25(6):371

461 Chiappini B,Martin-Suarez S,LoF orte A,et al.Cox/maze III operation versus radiofrequency ablation for the surgical treatment of atrial fibrillation:a comparative study[J].Ann Thorac Surg,2004,77(1):87

462 Lall SC,Melby SJ,Voeller RK,et al.The effect of ablation technology on surgical outcomes after the Cox-maze procedure:a propensity analysis[J].J Thorac Cardiovasc Surg,2007,133(2):389

463 Doty JR,Doty DB,Jones KW,et al.Comparison of standard Maze III and radiofrequency Maze operations for treatment of atrial fibrillation[J].J Thorac Cardiovasc Surg,2007,133(4):1 037

464 Rahman NM,Chard RB,Thomas SP.Outcomes for surgical treatment of atrial fibrillation using cryoablation during concomitant cardiac procedures[J].Ann Thorac Surg,2010,90(5):1 523

465 Funatsu T,Kobayashi J,Nakajima H,et al.Long-term results and reliability of cryothermic ablation based maze procedure for atrial fibrillation concomitant with mitral valve surgery[J].Eur J Cardiothorac Surg,2009,36(2):267

466 Cox JL.A brief overview of surgery for atrial fibrillation[J].Ann Cardiothorac Surg,2014,3(1):80

467 Ad N,Suri RM,Gammie JS,et al.Surgical ablation of atrial fibrillation trends and outcomes in North America[J].J Thorac Cardiovasc Surg,2012,144(5):1 051

468 Gillinov AM,Gelijns AC,Parides MK,et al.Surgical ablation of atrial fibrillation during mitral-valve surgery[J].N Engl J Med,2015,372(15):1 399

469 La Meir M,Gelsomino S,Nonneman B.The problem with concomitant atrial fibrillation in non-mitral valve surgery[J].Ann Cardiothorac Surg,2014,3(1):124

470 Phan K,Xie A,Tsai YC,et al.Biatrial ablation vs.left atrial concomitant surgical ablation for treatment of atrial fibrillation:a meta-analysis[J].Europace,2015,17(1):38

471 Zheng S,Zhang H,Li Y,et al.Comparison of left atrial and biatrial maze procedure in the treatment of atrial fibrillation:A meta-analysis of clinical studies[J].J Thorac Cardiovasc Surg,2015,Epub ahead of print]

472 Krul SPJ,Driessen AHG,van Boven WJ,et al.Thoracoscopic video-assisted pulmonary vein antrum isolation,ganglionated plexus ablation,and periprocedural confirmation of ablation lesions first results of a hybrid surgical-electrophysiological approach for atrial fibrillation[J].Circ-Arrhythmia Electrophysiol,2011,4(3):262

473 Edgerton JR,Brinkman WT,Weaver T,et al.Pulmonary vein isolation and autonomic denervation for the management of paroxysmal atrial fibrillation by a minimally invasive surgical approach[J].J Thorac Cardiovasc Surg,2010,140(4):823

474 Bagge L,Blomstrom P,Nilsson L,et al.Epicardial off-pump pulmonary vein isolation and vagal denervation improve long-term outcome and quality of life in patients with atrial fibrillation[J].J Thorac Cardiovasc Surg,2009,137(5):1 265

475 Han FT,Kasirajan V,Kowalski M,et al.Results of a minimally invasive surgical pulmonary vein isolation and ganglionic plexi ablation for atrial fibrillation single-center experience with 12-month follow-up[J].Circ-Arrhythmia Electrophysiol,2009,2(4):370

476 Yilmaz A,Geuzebroek GSC,Van Putte BP,et al.Completely thoracoscopic pulmonary vein isolation with ganglionic plexus ablation and left atrial appendage amputation for treatment of atrial fibrillation[J].Eur J Cardiothorac Surg,2010,38(3):356

477 Hu QM,Li Y,Xu CL,et al.Analysis of risk factors for recurrence after video-assisted pulmonary vein isolation of lone atrial fibrillation-results of 5 years of follow-up[J].J Thorac Cardiovasc Surg,2014,148(5):2 174

478 De Maat GE,Pozzoli A,Scholten MF,et al.Long-term results of surgical minimally invasive pulmonary vein isolation for paroxysmallone atrial fibrillation[J].Europace,2015,17(5):747

479 Shinbane JS,Lesh MD,Stevenson WG,et al.Anatomic and electrophysiologic relation between the coronary sinus and mitral annulus:implications for ablation of left-sided accessory pathways[J].Am Heart J,1998,135(1):93

480 Edgerton JR,Jackman WM,Mack MJ.A new epicardial lesion set for minimal access left atrial maze:the dallas lesion set[J].Ann Thorac Surg,2009,88(5):1655

481 Edgerton JR,Jackman WM,Mahoney C,et al.Totally thorascopic surgical ablation of persistent AF and long-standing persistent atrial fibrillation using the"Dallas"lesion set[J].Heart Rhythm,2009,6(12):S64

482 Wang JG,Xin M,Han J,et al.Ablation in selective patients with long-standing persistent atrial fibrillation:medium-term results of the Dallas lesion set[J].Eur J Cardiothorac Surg,2014,46(2):213

483 Kim TH,Park J,Park JK,et al.Linear ablation in addition to circumferential pulmonary vein isolation(Dallas lesion set)does not improve clinical outcome in patients with paroxysmal atrial fibrillation:a prospective randomized study[J].Europace,2015,17(3):388

484 Wang JG,Li Y,Shi JH,et al.Minimally invasive surgical versus catheter ablation for the long-lasting persistent atrial fibrillation[J].PloS one,2011,6(7)

485 Boersma LVA,Castella M,van Boven W,et al.Atrial fibrillation catheter ablation versus surgical ablation treatment(FAST):a 2-center randomized clinical trial[J].Circulation,2012,125(1):23

486 Hoogsteen J,Schep G,van Hemel NM,et al.Paroxysmal atrial fibrillation in male endurance athletes.A 9-year follow up[J].Europace,2004,6(3):222

487 Calvo N,Mont L,Tamborero D,et al.Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes[J].Europace,2010,12(1):30

488 Wyse DG.Pharmacotherapy for rhythm management in elderly patients with atrial fibrillation[J].J Interv Card Electrophysiol,2009,25(1):25

489 Maron BJ.Hypertrophic cardiomyopathy[J].Lancet(London,England),1997,350(9071):127

490 Tendera M,Wycisk A,Schneeweiss A,et al.Effect of sotalol on arrhythmias and exercise tolerance in patients with hypertrophic cardiomyopathy[J].Cardiology,1993,82(5):335

491 Bunch TJ,Munger TM,Friedman PA,et al.Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy[J].J Cardiovasc Electrophysiol,2008,19(10):1 009

492 Gaita F,Di Donna P,Olivotto I,et al.Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy[J].Am J Cardiol,2007,99(11):1 575

493 Chen MS,McC arthy PM,Lever HM,et al.Effectiveness of atrial fibrillation surgery in patients with hypertrophic cardiomyopathy[J].Am J Cardiol,2004,93(3):373

494 Crenshaw BS,Ward SR,Granger CB,et al.Atrial fibrillation in the setting of acute myocardial infarction:the GUSTO-I experience.Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries[J].J Am Coll Cardiol,1997,30(2):406

495 Rathore SS,Berger AK,Weinfurt KP,et al.Acute myocardial infarction complicated by atrial fibrillation in the elderly——prevalence and outcomes[J].Circulation,2000,101(9):969

496 McM urray J,Kober L,Robertson M,et al.Antiarrhythmic effect of carvedilol after acute myocardial infarction——Results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction(CAPRICORN)trial[J].J Am Coll Cardiol,2005,45(4):525

497 Frost L,Vestergaard P,Mosekilde L.Hyperthyroidism and risk of atrial fibrillation or flutter——A population-based study[J].Arch Intern Med,2004,164(15):1 675

498 Petersen P.Thromboembolic complications in atrial fibrillation[J].Stroke,1990,21(1):4

499 Agner T,Almdal T,Thorsteinsson B,et al.A reevaluation of atrial fibrillation in thyrotoxicosis[J].Dan Med Bull,1984,31(2):157

500 Traube E,Coplan NL.Embolic risk in atrial fibrillation that arises from hyperthyroidism:review of the medical literature[J].Tex Heart Inst J,2011,38(3):225

501 Petersen P,Hansen JM.Stroke in thyrotoxicosis with atrial fibrillation[J].Stroke,1988,19(1):15

502 Dunning J,Treasure T,Versteegh M,et al.Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery[J].Eur J Cardiothorac Surg,2006,30(6):852

503 Fuso L,Incalzi RA,Pistelli R,et al.Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease[J].Am J Med,1995,98(3):272

504 McC ord J,Borzak S.Multifocal atrial tachycardia[J].Chest,1998,113(1):203

505 Goldman S,Probst P,Selzer A,et al.Inefficacy of"therapeutic"serum levels of digoxin in controlling the ventricular rate in atrial fibrillation[J].Am J Cardiol,1975,35(5):651

506 Pietersen AH,Andersen ED,Sandoe E.Atrial fibrillation in the Wolff-Parkinson-White syndrome[J].Am J Cardiol,1992,70(5):38A

507 Zardini M,Yee R,Thakur RK,et al.Risk of sudden arrhythmic death in the Wolff-Parkinson-White syndrome:current perspectives[J].Pacing Clin Electrophysiol,1994,17(5 Pt 1):966

508 Blomstrom-Lundqvist C,Scheinman MM,Aliot EM,et al.ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias——Executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines(writing committee to develop guidelines for the management of patients with supraventricular arrhythmias)[J].Circulation,2003,108(15):1 871

509 Simonian SM,Lotfipour S,Wall C,et al.Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation[J].Intern Emerg Med,2010,5(5):421

510 Akhtar M,Gilbert CJ,Shenasa M.Effect of lidocaine on atrioventricular response via the accessory pathway in patients with WolffParkinson-White syndrome[J].Circulation,1981,63(2):435

511 Dolla E,Levy S,Cointe R,et al.Oral propranolol in Wolff-Parkinson-White syndrome.Electrophysiological data[J].Arch Mal Coeur Vaiss,1991,84(7):917

512 Tsang TSM,Gersh BJ,Appleton CP,et al.Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women[J].J Am Coll Cardiol,2002,40(9):1 636

513 夏文芳,于胜波,黄鹤,等.心房颤动对慢性收缩性心力衰竭患者和射血分数正常心力衰竭患者预后的影响[J].中国心脏起搏与心电生理杂志,2014,28(5):423

514 Roy D,Talajic M,Nattel S,et al.Rhythm control versus rate control for atrial fibrillation and heart failure[J].N Engl J Med,2008,358(25):2 667

515 Bortone A,Pujadas-Berthault P,Karam N,et al.Catheter ablation in selected patients with depressed left ventricular ejection fraction and persistent atrial fibrillation unresponsive to current cardioversion[J].Europace,2013,15(11):1 574

516 Brignole M,Botto G,Mont L,et al.Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation:a randomized trial[J].Eur Heart J,2011,32(19):2 420

517 Upadhyay GA,Choudhry NK,Auricchio A,et al.Cardiac resynchronization in patients with atrial fibrillation——a meta-analysis of prospective cohort studies[J].J Am Coll Cardiol,2008,52(15):1 239

518 Darbar D,Herron KJ,Ballew JD,et al.Familial atrial fibrillation is a genetically heterogeneous disorder[J].J Am Coll Cardiol,2003,41(12):2 185

519 Lubitz SA,Yin XY,Fontes JD,et al.Association between familial atrial fibrillation and risk of new-onset atrial fibrillation[J].JAMA-J Am Med Assoc,2010,304(20):2 263

520 Lubitz SA,Ozcan C,Magnani JW,et al.Genetics of atrial fibrillation implications for future research directions and personalized medicine[J].Circ-Arrhythmia Electrophysiol,2010,3(3):291

521 Benjamin EJ,Rice KM,Arking DE,et al.Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry[J].Nat Genet,2009,41(8):879

522 Ellinor PT,Lunetta KL,Albert CM,et al.Meta-analysis identifies six new susceptibility loci for atrial fibrillation[J].Nat Genet,2012,44(6):670

523 Ackerman MJ,Priori SG,Willems S,et al.HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies[J].Heart Rhythm,2011,8(8):1 308

524 Mehra R,Benjamin EJ,Shahar E,et al.Association of nocturnal arrhythmias with sleep-disordered breathing——The Sleep Heart Health Study[J].Am J Respir Crit Care Med,2006,173(8):910

525 Guilleminault C,Connolly SJ,Winkle RA.Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome[J].Am J Cardiol,1983,52(5):490

526 Gami AS,Friedman PA,Chung MK,et al.Therapy insight:interactions between atrial fibrillation and obstructive sleep apnea[J].Nat Clin Pract Cardiovasc Med,2005,2(3):145

527 Monahan K,Storfer-Isser A,Mehra R,et al.Triggering of nocturnal arrhythmias by sleep-disordered breathing events[J].J Am Coll Cardiol,2009,54(19):1 797

528 Neilan TG,Farhad H,Dodson JA,et al.Effect of sleep apnea and continuous positive airway pressure on cardiac structure and recurrence of atrial fibrillation[J].J Am Heart Assoc,2013,2(6):e000 421

529 Ng CY,Liu T,Shehata M,et al.Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation[J].Am J Cardiol,2011,108(1):47

530 Ommen SR,Odell JA,Stanton MS.Atrial arrhythmias after cardiothoracic surgery[J].N Engl J Med,1997,336(20):1 429

531 Echahidi N,Pibarot P,O'Hara G,et al.Mechanisms,prevention,and treatment of atrial fibrillation after cardiac surgery[J].J Am Coll Cardiol,2008,51(8):793

532 Zimmer J,Pezzullo J,Choucair W,et al.Meta-analysis of antiarrhythmic therapy in the prevention of postoperative atrial fibrillation and the effect on hospital length of stay,costs,cerebrovascular accidents,and mortality in patients undergoing cardiac surgery[J].Am J Cardiol,2003,91(9):1 137

533 Crystal E,Garfinkle MS,Connolly SS,et al.Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery[J].Cochrane Database Syst Rev,2004,(4):CD003611

534 Daoud EG,Strickberger SA,Man KC,et al.Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery[J].N Engl J Med,1997,337(25):1 785

535 Kuhn EW,Slottosch I,Wahlers T,et al.Preoperative statin therapy for patients undergoing cardiac surgery[J].Cochrane Database Syst Rev,2015,8:CD008493

536 Guarnieri T,Nolan S,Gottlieb SO,et al.Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery:the Amiodarone Reduction in Coronary Heart(ARCH)trial[J].J Am Coll Cardiol,1999,34(2):343

537 Mitchell LB,Exner DV,Wyse DG,et al.Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization,valve replacement,or repair(PAPABEAR):a randomized controlled trial[J].JAMA,2005,294(24):3 093

538 Mooss AN,Wurdeman RL,Mohiuddin SM,et al.Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation/atrial flutter after open heart surgery[J].Am Heart J,2000,140(1):176

539 Tisdale JE,Padhi ID,Goldberg AD,et al.A randomized,doubleblind comparison of intravenous diltiazem and digoxin for atrial fibrillation after coronary artery bypass surgery[J].Am Heart J,1998,135(5 Pt 1):739

540 Di Biasi P,Scrofani R,Paje A,et al.Intravenous amiodarone vs propafenone for atrial fibrillation and flutter after cardiac operation[J].Eur J Cardiothorac Surg,1995,9(10):587

541 Hunt SA,Baker DW,Chin MH,et al.ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult:executive summary.a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure):Developed in Collaboration With the International Society for Heart and Lung Transplantation;Endorsed by the Heart Failure Society of America[J].Circulation,2001,104(24):2 996

542 Ali IM,Sanalla AA,Clark V.Beta-blocker effects on postoperative atrial fibrillation[J].Eur J Cardiothorac Surg,1997,11(6):1 154

543 Khoo CW,Lip GY.Acute management of atrial fibrillation[J].Chest,2009,135(3):849

544 Nakazato Y,Yasuda M,Sasaki A,et al.Conversion and maintenance of sinus rhythm by bepridil in patients with persistent atrial fibrillation[J].Circ J,2005,69(1):44

545 Raghavan AV,Decker WW,Meloy TD.Management of atrial fibrillation in the emergency department[J].Emerg Med Clin North Am,2005,23(4):1 127

546 Olshansky B,Guo H.Acute anticoagulation adjustment in patients with atrial fibrillation at risk for stroke:approaches,strategies,risks and benefits[J].Expert Rev Cardiovasc Ther,2005,3(4):571

547 Bradley D,Creswell LL,Hogue CW,et al.Pharmacologic prophylaxis:American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery[J].Chest,2005,128(2 Suppl):39S

548 Kinebuchi O,Mitamura H,Shiroshita-Takeshita A,et al.Oral verapamil attenuates the progression of pacing-induced electrical and mechanical remodeling of the atrium[J].Circ J,2004,68(5):494

549 Taylor DM,Aggarwal A,Carter M,et al.Management of new onset atrial fibrillation in previously well patients less than 60 years of age[J].Emerg Med Australas,2005,17(1):4

550 Jasper SE,Lieber EA,Murray RD,et al.Impact of cardioversion strategy on functional capacity in patients with atrial fibrillation:the Assessment of Cardioversion Using Transesophageal Echocardiography(ACUTE)study[J].Am Heart J,2005,149(2):309

551 Tuseth V,Jaatun HJ,Dickstein K.Amiodarone infusion in the treatment of acute atrial fibrillation or flutter:high versus low dose treatment[J].Heart,2005,91(7):964